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ABSTRACT
Reisdorph, Cassie, Ph.D., Spring 2022

Integrative Physiology & Rehabilitation Sciences

Traditional vs. Home-Based Phase II Cardiac Rehabilitation in Rural Montana During COVID19: A Retrospective Study
Chairperson: John C. Quindry, Ph.D.
This dissertation addresses the following questions: 1) the impact of three environmental
conditions (altitude, heat, and woodsmoke exposure) on the blood oxidative stress response to
exercise; 2) the effect of exercise-based cardiac rehabilitation programs (home-based, HBCR;
traditional, TCR) on health outcomes in those who have experienced a cardiovascular event and/or
severe diagnosis resulting in referral to cardiac rehabilitation. Study 1: Examine effects of labsimulated hypobaric and hypoxic conditions on oxidative stress during a 4-hour recovery period
after 1-hour of cycling (70% watts max). Exercise increased markers of antioxidant status (TEAC,
FRAP) and lipid damage (8-ISO) (p<0.05). No effects of hypobaria and hypoxia were observed.
Study 2: Compare the blood oxidative stress response to an exercise tolerance trial (1-hour, 50%
Wpeak) in hot (33ºC) and room temperature (20ºC) environments following acclimation training
(15 sessions). Exercise increased markers of antioxidant status (TEAC, FRAP) and lipid damage
(LOOH) (p<0.001). No effect of environmental temperature was observed. Study 3: Investigate
the effect of woodsmoke exposure (200 µg·m-3) on variables of cardiovascular function (heart rate
variability, HRV; pulse wave velocity PWV) and oxidative stress with 45-min of moderateintensity exercise (70% VO2max). Woodsmoke exposure did not reduce HRV, increase PWV, or
increase oxidative stress (p>0.05). Study 4: The final study was conducted to compare the
effectiveness of TCR and HBCR as determined by improvements in exercise capacity (peak
metabolic equivalents, peak METs), resting heart rate (RHR), resting systolic (SBP) and diastolic
(DBP) blood pressure, body mass index (BMI), and depression outcomes (PHQ-9). Peak METs
and PHQ-9 scores improved in both TCR and HBCR (p<0.001); however, greater improvements
in peak METs occurred with TCR (p=0.034). No association between intervention type and
program completion was observed (p=0.172). The results of these investigations indicate 1) labsimulated hypobaric and/or hypoxic conditions do not impact the oxidative stress response to
exercise; 2) 15 sessions of acclimation training in a hot environment do not alter the oxidative
stress response to an exercise tolerance trial; 3) Woodsmoke exposure (200 µg·m-3) with moderateintensity exercise did not negatively impact HRV, PWV or blood oxidative stress; 4) HBCR and
TCR improve peak METs and PHQ-9 outcomes.
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Chapter I: Introduction
EXERCISE AND CARDIOVASCULAR HEALTH
Regular exercise is essential for the prevention of cardiovascular disease (CVD). Consistent
exercise reduces risk, delays onset, and diminishes the severity of CVD1, 2. Additional benefits of
physical activity include reduced blood pressure, improved insulin sensitivity, and reduced risk of
hypertension, depression, or diabetes development, to name a few3. For this reason, the American
Heart Association (AHA), American College of Cardiology (ACC), and the American College of
Sports Medicine (ACSM) all recommend that adults participate in a regular exercise program1, 4.
The 2008 Physical Activity Guidelines state that all adults should achieve at least 150 minutes per
week of moderate-intensity exercise to improve health outcomes. Unfortunately, less than onethird of Americans achieve these guidelines2.
OXIDATIVE STRESS: ADAPTIVE VS. MALADAPTIVE
Oxidative stress occurs with a shift in the oxidant-antioxidant balance, which results in free radical
production that exceeds antioxidant capacity5-7. Acute disruptions, such as those that occur with
exercise, are expected and necessary for adaptation8-11. However, oxidative stress can be
maladaptive when chronic, and lead to various disease states5, 8-11. Chronic oxidative stress is a
significant factor in the pathophysiology of CVD and plays a role in disease progression5, 8, which
likely includes individuals who have experienced cardiovascular events and/or a diagnosis severe
enough to result in referral to cardiac rehabilitation. The established relationship between
perturbations in blood oxidative stress and exercise adaptations highlights the necessity of gaining
insight into the acute response under several conditions typically experienced during recreational
exercise (e.g., heat, altitude).
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SUMMARY
The overarching theme of this dissertation centers on the idea that oxidative stress can be adaptive
or maladaptive. The first three investigations focused on the acute aspect of oxidative stress, with
the goal of examining the impact of various environmental conditions (e.g., altitude, heat,
woodsmoke) on the blood oxidative stress response to exercise. Recreational exercisers self-select
into exercise, regardless of the environmental conditions, which highlights the need to gain insight
into the influence of the environment on the blood oxidative stress response. Finally, the last
investigation within this dissertation focused on the impact of exercise after maladaptation
occurred. The final study examined the impact of two different cardiac rehabilitation interventions
(traditional vs. home-based) on cardiovascular health outcomes, including exercise capacity (peak
METs), resting heart rate (RHR), systolic blood pressure (SBP), diastolic blood pressure (DBP),
body mass index (BMI), and depression scores (PHQ-9).
STUDY 1: Examination of the Independent Effects of Hypobaria and Hypoxia on the
Blood Oxidative Stress Response to Acute Exercise
Acute exercise elicits transient perturbations in redox balance resulting in elevated blood oxidative
stress9,

11-13

. Chronic, long-term oxidative stress negatively impacts health, but short-term

disruptions are necessary for exercise adaptations12. Recreational exercisers self-select into
exercise under various environmental conditions (e.g., altitude), and it is well-established that
variations in the environment can influence oxidative stress responses during and following
exercise14-17. Even under resting conditions, high altitude amplifies the oxidative stress response,
which could be further exacerbated by exercise18, 19. Well-controlled laboratory studies have
examined the isolated effects of hypoxia, some of which demonstrated an attenuation of the
oxidative stress response during the post-exercise recovery period, while others exhibited no effect
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of hypoxia14, 15, 17. A gap in knowledge remains regarding the independent effect of hypobaric
conditions. The investigation utilized a randomized, crossover design to examine the independent
effects of hypoxia and hypobaria on the blood oxidative stress response to moderate-intensity
cycling exercise (1-hour, 70% peak watts). Three exercise trials were conducted under the
following conditions: normobaric-normoxia (NN), hypobaric-hypoxia (HH), and normobarichypoxia (NH). A strategic panel of blood oxidative stress markers were quantified at baseline
(Pre), after exercise (Post), and at two-hours (2Hr) and four-hours (4Hr) during the post-exercise
recovery period. The hypothesis was that both hypoxic and hypobaric conditions would result in a
blunting of oxidative stress during the post-exercise recovery period.
STUDY 2: Comparison of Blood Oxidative Stress Response to Acute Exercise in the Heat
after 15 Temperature Acclimation Sessions
Oxidative stress occurs with excessive production of reactive oxygen species (ROS) that exceeds
antioxidant capacity, which provokes damage to cellular components20. Chronic oxidative stress
is a significant contributor to the pathophysiology of various diseases; however, acute disruptions
to the oxidant-antioxidant balance are necessary for exercise adaptions12, 20-22. Individuals selfselect into exercise under a variety of environmental conditions, one of which is exercise in hot
ambient temperatures. Ambient temperature increases oxidative stress independent of exercise,
and the oxidative stress response is exacerbated with exercise under hyperthermic conditions23-25.
While the blood oxidative stress response to a single, acute bout of exercise in a hot environment
is well documented, the effects of hyperthermic exercise training remain understudied. To date,
one investigation has examined the effects of four-weeks of high-intensity interval training (HIIT)
in a hot environment on the blood oxidative stress response. Findings determined that lipid damage
was elevated, and protein damage was blunted following the training period26. Further
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investigation is necessary to understand the impact of hyperthermic exercise training on the blood
oxidative stress response with various exercise modalities and/or intensities. The investigation
assigned untrained participants to one of two groups: hot (32°C, 40% Relative Humidity) or room
temperature (18°C, 40% Relative Humidity). Pre- and post- exercise tolerance trials (1-hour, 50%
Wpeak) were separated by 15 exercise training sessions in the assigned temperature. For the exercise
tolerance trials, blood oxidative stress was quantified before exercise (Pre), after exercise (Post),
and at two-hours (2Hr) and four-hours (4Hr) during the recovery period.
STUDY 3: Examination of Woodsmoke Exposure on the Blood Oxidative Response to
Acute Exercise
Smoke inhalation resulting from biomass combustion is a significant, global public health problem
that is increasing due to frequent wildfires27. Inhalation of biomass particulate matter, including
airborne particles ≤ 2.5 microns in diameter, is associated with health dangers28. Populations
affected by PM2.5 include wildland firefighters, those who live within communities prone to
wildfires, and those who self-select into outdoor exercise and/or recreation during times of high
exposure. Due to the increased ventilatory rates associated with exercise, insight into the combined
effects of exercise and woodsmoke exposure is essential. Chronic exposure is associated with
reduced life expectancy and increased rates of cardiovascular disease29; however, the impact of
acute, short-term exposures remains understudied. The investigation utilized a randomized,
crossover design with two exposure trials (Woodsmoke: 200 µg·m-3, Filtered Air: 0 µg·m-3)
requiring 45-minutes of moderate-intensity exercise (70% VO2max) to examine the impact of
exposure on variables of cardiovascular function (heart rate variability, HRV; pulse wave velocity,
PWV) and the blood oxidative stress response. The hypothesis was that exercise while exposed to
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woodsmoke will negatively impact variables of cardiovascular function (decrease HRV, increase
PWV) and elevate blood oxidative stress.
STUDY 4: Comparison of Traditional vs. Home-based Cardiac Rehabilitation in a Rural
Montana Area During the COVID-19 Pandemic
Cardiovascular disease (CVD) caused ~ 17.8 million deaths worldwide in 2017, and it is the
leading cause of morbidity and mortality within the United States (US)30-33. The indirect and direct
cost of CVD was approximately $351.3 billion in 2015, which places a significant toll on the US
health care system32. CVD not only negatively impacts health care systems, but serves as a
significant affliction for those diagnosed, and greatly reduces quality of life34. With a prevalence
rate of 10.6% in 2017, it is evident that a substantial number of Americans are being burdened by
this disease32,

35

. Further, growth of CVD burden is expected to continue due to the aging

population, poor risk factor mitigation (e.g., increased prevalence of obesity), and lack of
prevention programs/strategies36.
Although it is well-established that physical activity improves risk factors and reduces CVD risk,
less than one-third of Americans meet the minimal recommendations2. Importantly, benefits of
consistent exercise are not limited to apparently healthy individuals. For instance, formal exercise
programs have demonstrated a 20-25% decrease in the death rate of those who have suffered a
myocardial infarction (MI)2. Exercise-related benefits for those with diagnosed CVD include
improvement of CVD risk factors, (e.g., exercise capacity, blood pressure, lipid panels), weight
reduction, and improved quality of life37, 38. Cardiovascular health benefits from regular exercise
engagement, in those with and without CVD, highlight the importance of increasing exercise
participation.
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Cardiac rehabilitation programs are leveraged as prescription-based exercise interventions
for those who have experienced a cardiac event and/or a diagnosis severe enough to trigger a
referral (e.g., coronary artery disease, heart failure)1, 39, 40. Cardiac rehabilitation programs focus
on exercise training and modifiable risk factor education (e.g., obesity), with the objective of
reducing the risk of secondary events and improving quality of life1, 39-41. Health-related benefits
of traditional cardiac rehabilitation programs are well-established within the scientific literature
and tend to focus on variables demonstrated to provide prognostic insight (e.g., exercise capacity,
resting heart rate) and/or CVD risk factors (e.g., hypertension). When considering health
outcomes, participation in rehabilitation has been demonstrated to reduce the risk of secondary
CVD events, decrease risk of rehospitalization, reduce the progression of atherosclerotic disease,
and improve physical functioning and quality of life40, 42, 43.
Exercise capacity, a known prognostic indicator of CVD risk, increases with participation in
traditional cardiac rehabilitation programs44-51. Araya-Ramírez et al. observed an approximate
20% improvement in 6-minute walk test performance in a cohort of 425 patients, which ultimately
led to improvements in mobilization and physical well-being44. Additionally, investigations have
demonstrated that participation in cardiac rehabilitation can decrease resting SBP, DBP, and
RHR38, 52, 53. For instance, Missiri et al. observed a reduction in RHR following 12-weeks of
traditional cardiac rehabilitation52. When considering risk factor mitigation, traditional cardiac
rehabilitation has been shown to reduce total cholesterol (TC) and low-density lipoproteins (LDLC), and increase high-density lipoproteins (HDL-C) in some patients48-50, 54-62. An investigation
examined 313 patients and determined that TC, LDL-C, and HDL-C were all improved following
cardiac rehabilitation63. Further evidence to support risk factor mitigation following cardiac
rehabilitation is demonstrated through BMI reduction46, 49, 57, 63-65. In a cohort of 500 patients,
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cardiac rehabilitation resulted in a significant reduction in BMI, in addition to other variables of
interest (e.g. quality of life)46. Despite the well-documented benefits of engagement in cardiac
rehabilitation programs, referral rates are low, and the programs remain underutilized41, 66, 67.
Due to the demonstrated efficacy of cardiac rehabilitation programs in the improvement of CVD
risk factors and outcomes, it is essential that health professionals strategize to increase
participation and adherence rates. In addition to low referral rates, patients diagnosed with CVD
consistently report barriers to program participation, such as increased age, difficulty obtaining
transportation to the rehabilitation center, and lengthy commute times/distances68-73. For instance,
Daly et al. determined that commute time was predictive of engagement and completion of cardiac
rehabilitation70. Further, those within rural communities are less likely to participate in
rehabilitation due to distance and transportation68. Not all barriers to participation are modifiable
(e.g., age); however, strategies are necessary to address those that are (e.g., commute).
Another important consideration regarding participation and adherence to cardiac rehabilitation
are sex-dependent differences in barriers to participation74-77. Females engage in cardiac
rehabilitation at a much lower rate than their male counterparts. Lower referral rates and lack of
encouragement for program entry are in part responsible for the deficiency in female enrollment
in cardiac rehabilitation; however, investigations have reported different barriers experienced by
female patients74. Notably, males and females both report variables such as age, comorbidities,
and transportation issues as barriers to program entry and completion75. However, females reported
greater time commitment and responsibilities within the home, and lack of support as significant
barriers to program entry75-77. Previous investigations observed improvements in female
participation when utilizing incentive programs, which provided flexible hours and alternative
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rehabilitation models75,

78, 79

. To address the unique barriers experienced by female patients,

additional intervention strategies must be explored.
Ultimately, reported barriers to program entry and completion must be taken into consideration,
and modifications to traditional programs are necessary to increase participation in cardiac
rehabilitation. Home-based approaches overcome the barriers of distance and transportation issues;
thus, further exploration should be conducted to better understand the advantages of home-based
programs. Therefore, the purpose of the investigation was to examine the effect of traditional
(TCR) and home-based (HBCR) phase II cardiac rehabilitation programs on prognostic variables
(peak METs, SBP, DBP, RHR), CVD risk factors (dyslipidemia, diabetes, BMI), and depression
scores (PHQ9).
Null Hypotheses
1. TCR and HBCR will not increase peak METs, and there will be no significant differences
between the two methods of rehabilitation.
2. TCR and HBCR will not decrease RHR, and there will be no significant differences between
the two methods of rehabilitation.
3. TCR and HBCR will not decrease SBP or DBP, and there will be no significant differences
between the two methods of rehabilitation.
4. TCR and HBCR will not decrease TC or LDL-C, and there will be no significant differences
between the two methods of rehabilitation.
5. TCR and HBCR will not increase HDL-C, and there will be no significant differences between
the two methods of rehabilitation.
6. TCR and HBCR will not decrease FBG or HbA1c, and there will be no significant differences
between the two methods of rehabilitation.
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7. TCR and HBCR will not improve depression outcomes, as determined by a decrease in the
PHQ-9 scores, and there will be no significant differences between the two methods of
rehabilitation.
8. There will be no significant association between the intervention method (TCR, HBCR) and
program completion.
Significance
As stated previously, CVD is the leading cause of morbidity and mortality, and
approximately 1 in 3 individuals within the United States is diagnosed with CVD, making this a
widespread issue30-33,

80

. Consistent exercise training has been demonstrated to mitigate risk

factors, decrease the risk of secondary cardiac events, and improve quality of life1, 32, 39-41, 81. For
this reason, it is essential to increase participation in cardiac rehabilitation for those with who
experienced a qualifying cardiac event or diagnosis. In addition to low referral rates, reported
barriers for enrollment in cardiac rehabilitation include lack of time, commute distance, and
difficulties due to transportation limitations42,

68-71, 81-83

. With the onset of the COVID-19

pandemic, a unique opportunity was presented to assess a relatively large sample within Montana
communities that were given a new opportunity to enroll in a HBCR program.71.
In addition to evaluation of TCR and HBCR programs, the investigation will examine sexdependent differences in both physiological outcomes and responses to TCR and HBCR programs.
Female participation in cardiac rehabilitation is historically lower than males, and females
experience different barriers to program enrollment75-77. Consequently, the findings of the
proposed investigation will be useful in identifying whether one type of program will improve
program completion in females84-87. Thus, the secondary purpose the investigation will be to
examine sex-dependent differences in health outcomes and completion rates with TCR and HBCR.
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Delimitations
1. Research participants were male and female cardiac rehabilitation patients who enrolled in and
completed the cardiac rehabilitation program at St. Patrick’s Hospital between October 1st,
2020 and March 31st, 2022.
2. Physical activity was only quantified within the cardiac rehabilitation setting and information
regarding physical activity prior to enrollment will not be considered.
3. Procedures for quantification of the metabolic panel were conducted based upon the guidelines
set by St. Patrick’s Hospital.
4. The current investigation did not account for dietary habits throughout the duration of the
study.
5. An estimation of peak METs was selected for this investigation to quantify exercise capacity.
6. RHR and resting SBP and DBP were selected for the investigation to evaluate the efficacy of
the cardiac rehabilitation interventions.
7. Lipid panels (TC, LDL-C, HDL-C) were selected to assess the efficacy of the cardiac
rehabilitation intervention to reduce CVD risk factors.
8. FBG and HbA1c, assessments of glucose control/diabetes, were selected to evaluate risk factor
reduction following cardiac rehabilitation.
9. BMI, a measurement of body fat based on weight and height, was selected for the investigation
as an assessment of obesity.
10. The PHQ9 score was selected for the investigation to evaluate depression.
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Limitations
1. Research participants were a convenience sample from the cardiac rehabilitation program at
St. Patrick’s Hospital in Missoula, MT who enrolled and completed between October 1st, 2020
and March 31st, 2022.
2. Previous physical activity levels prior to program enrollment were not be quantified; thus, it is
unknown whether the prescribed amount of activity within the rehabilitation program exceeded
previous activity levels.
3. Blood sampling for the metabolic panel was not guaranteed to be conducted in a fasted state.
4. Dietary habits were not monitored or controlled for.
5. The estimation of peak METs did not provide a direct measurement of aerobic capacity.
6. RHR and resting SBP and DBP fluctuate daily, and they are influenced by variables external
to the investigation (e.g., sleep, stress, medications).
7. Lipid panels are significantly affected by lifestyle choices that occur outside of cardiac
rehabilitation (e.g., diet, habitual physical activity).
8. FBG and HbA1c are influenced by variables outside of the investigation (e.g., diet, physical
activity). Additionally, HbA1c provides a 90-day average; thus, interventions ≤ 90-days may
not capture significant changes in HbA1c.
9. BMI does not distinguish between body fat, muscle mass, and bone.
10. The PHQ9 is a survey-based screening instrument that may not be as effective for identification
of depression as a comprehensive diagnostic assessment by a medical professional.
Assumptions
1. The research participants are a representative sample of all cardiac rehabilitation patients
within the United States.
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2. Physical activity levels prior to cardiac rehabilitation enrollment did not impact physiological
outcomes monitored within the study.
3. Variables quantified in the metabolic panel are still clinically meaningful, even if they were
not collected under fasted conditions.
4. Even though dietary habits were not considered, the effect of an exercise intervention on
cardiovascular risk factors were detectable.
5. The estimation of peak METs correlates with a direct measurement of exercise capacity (e.g.,
VO2max).
6. RHR and resting SBP and DBP provided prognostic insight, even if the measurements are
affected by variables that the investigation could not control.
7. Lipid panels provided information regarding the efficacy of exercise to reduce CVD risk
factors, even if variables outside of the study could not be controlled.
8. FBG and HbA1c are beneficial in the evaluation of risk factor reduction, even though these
variables are impacted by factors outside of the proposed investigation. Additionally, some of
the interventions will be > 90-days; thus, it was possible to observe changes in HbA1c.
9. Elevated BMI is associated with certain obesity-related health conditions and mortality.
10. PHQ9 scores correlate with a clinical diagnosis of depression.
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Chapter II: Review of Literature
EXERCISE AND CARDIOVASCULAR HEALTH
Regular exercise is a significant lifestyle modification for the prevention of cardiovascular disease
(CVD). Consistent exercise reduces risk, delays onset, and diminishes the severity of CVD1, 2.
Consequently, it is recommended that all adults participate in a regular exercise program1, 4. The
2008 Physical Activity Guidelines state that all adults should achieve at least 150 minutes per week
of moderate-intensity exercise to improve health outcomes. Although it is well-established that
physical activity improves risk factors and reduces CVD risk, less than one-third of Americans
meet the minimal recommendations2.
CVD is the leading cause of morbidity and mortality in the United States, and it places a significant
burden on the health care system30, 31, 33. Benefits of consistent exercise are not limited to those
without diagnosed CVD. For instance, exercise programs decrease the death rate by 20-25% for
individuals who suffered a myocardial infarction (MI)2. Exercise-related benefits for those with
diagnosed CVD include improvement of CVD risk factors, (e.g., exercise capacity, blood pressure,
lipid panels), weight reduction, and improved quality of life37, 38. Cardiovascular health benefits
from regular exercise engagement, in those with and without CVD, highlight the importance of
increasing exercise participation.
OXIDATIVE STRESS
Oxidative stress is a significant factor in the pathophysiology of CVD and plays a role in disease
progression5, 8. Oxidative stress is a disruption in the oxidant-antioxidant balance that occurs when
free radical production exceeds antioxidant capacity5-7. Free radicals are atoms/molecules with an
unpaired electron, which makes it unstable and highly reactive, and ultimately leads to cellular
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damage6, 88. Under homeostatic conditions, there is a balance between free radical production and
antioxidant capacity; however, when the scale tips, there is an increase in the production of free
radicals and a concomitant decrease in antioxidants88. Acute perturbations in the oxidantantioxidant balance are expected and necessary for adaptation; however, chronic disruptions can
result in several disease states (e.g., hypertension, diabetes, CVD) 8-11. Environmental factors, such
as exercise, radiation, smoking, alcohol consumption, and other stressful stimuli result in free
radical production, ultimately causing a cascade of reactions that elicit oxidative damage in
carbohydrates, proteins, lipids, and nucleic acids5-7, 89.
Free radicals are short-lived; thus, when quantifying oxidative stress, it is recommended that
measurements focus instead on the resulting cellular damage and/or decreases in antioxidant
capacity. A shift to a pro-oxidant state should theoretically decrease antioxidants, indicating
oxidative stress. Antioxidant status can be quantified through the measurement of ferric-reducing
ability of plasma (FRAP) and Trolox equivalent antioxidant capacity (TEAC). The initiation of
the cascade and resultant chain reactions previously mentioned can damage lipids, proteins, and
DNA. Therefore, quantification of oxidative stress include measurement of redox-sensitive
molecules that responds to the stress (e.g., exercise). Markers of damage include the lipid (8isoprostane, 8-ISO; lipid hydroperoxides, LOOH) and protein markers (protein carbonyls, PC; 3nitrotyrosine, 3-NT)6, 10, 14-17, 23, 90-94. Important considerations in the quantification of oxidative
stress include clearance rates; thus, the panel of biomarkers should include short- (8-ISO, 3-NT)
and long- term (LOOH, PC) markers.
Acute perturbations in redox balance occur with exercise in both an intensity- and durationdependent manner9. Acute shifts in oxidant-antioxidant balance are necessary to elicit adaptations
to exercise95. TEAC and FRAP become elevated with exercise in an intensity-dependent manner10,
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14, 15, 17, 90, 96

. Investigations have determined that 8-ISO and LOOH are elevated from baseline

values in response to exercise10, 96-99. For instance, McAnulty et al. demonstrated a significant
increase in 8-ISO and LOOH following a 3-hour treadmill at moderate-intensity (70% VO2max)96.
Exercise-induced elevations of 8-ISO can remain for up to 24-hours following exercise, depending
on the duration and/or intensity of the exercise10, 98. Additionally, LOOH are elevated with exercise
and continue to increase throughout recovery17. Protein oxidation is indicated by elevations in 3NT and PC, which occurs with high-intensity or long-duration exercise15, 100, 101. Ballman et al.
observed elevations in PC following high-intensity cycling (2 min at 80% VO2max and 12 min at
50% VO2max), and it remained elevated until 4-hours post-exercise15. PC increases with exercise
lasting 120-minutes; however, this has not been observed following 30- or 60- minute exercise102.
Protein oxidation responses may be influenced by an individual’s sex and/or training status100, 103.
While exercise-induced shifts are beneficial for adaptations, chronic oxidative stress leads to
various disease states5, 8-11. Regarding CVD, modifications due to oxidative stress can impact
contractility through oxidation of sarco/endoplasmic reticulum Ca2+-ATPase (SERCA 2a), disrupt
the NO signaling pathway leading to endothelial dysfunction, and/or cause mitochondrial
dysfunction via increased ROS production5, 104, 105. Chronic oxidative stress can lead to metabolic
syndrome, cardiac hypertrophy, heart failure, and myocardial infarction, to name a few5, 106-109.
Due to the role of oxidative stress in the pathophysiology of CVD development and progression,
as well as the necessity for transient perturbations for adaptations, a thorough understanding of
exercise and oxidant-antixoidant balance are essential.
OXIDATIVE STRESS AND EXERCISE AT ALTITUDE
Historically, exercise-induced oxidative stress was considered an adverse response that required
prevention (e.g., antioxidant supplementation) due to the relationship between ROS production
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and muscle fatigue110, 111. However, scientific evidence has provided a clear understanding that
transient perturbations in redox balance are essential for exercise-induced adaptations12,

112

.

Oxidative stress is a careful balancing act between this adaptive response, and the persistent,
chronic oxidative stress (maladaptive response) associated with the development of disease states
(e.g., CVD)7-9, 88. Importantly, recreational exercisers self-select into exercise under a variety of
environmental conditions (e.g., heat, altitude), highlighting the necessity of understanding the
oxidative stress response to exercise and exercise recovery at high altitude. Even under resting
conditions, high altitude has been demonstrated to increase the blood oxidative stress response and
could be exacerbated by exercise18,

19, 113

. Thus, an understanding of the combined effect of

exercise and high altitude is warranted.
The blood oxidative stress response to exercise at high altitude has been examined in field-based
research and well-controlled laboratory studies utilizing environmental chambers14-16. Miller et al.
conducted a field-based examination of blood oxidative stress responses to a two-day, high-altitude
trek on Mount Rainier (Day 1: 6.25 hours, Peak Altitude: 3,000 m; Day 2: 5 hours, Peak Altitude:
4,393m). Blood oxidative stress markers of antioxidant status (TEAC, FRAP), protein damage
(PC), and lipid damage (LOOH) were all elevated in response to the high-altitude trek16.
Findings from the field-based investigation provided insight into the oxidative stress response to a
high-altitude trek; however, the independent effect of hypoxia could not be determined. Laboratory
investigations have examined the effect of hypoxia, independent of other variables that occur at
high altitude (e.g., hypobaria, environmental temperature) on exercise and the post-exercise
recovery period. McGinnis et al. compared the effect of a one-hour bout of cycle ergometry (60%
VO2peak) under hypoxic conditions (3,000 m) and normoxic conditions (975 m) on blood oxidative
stress responses. A significant elevation of the lipid damage marker, LOOH, occurred with
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hypoxic exercise and remained elevated through the four-hour recovery period. However, markers
of antioxidant status (TEAC, FRAP) and protein damage (PC) were affected by hypoxia. An
additional investigation examined the post-exercise recovery period under hypoxic conditions and
demonstrated a significant blunting of blood oxidative stress response15. The necessity of exerciseinduced oxidative stress for adaptation speaks to the importance of this finding; thus, future
research is necessary to understand the implications of exercise recovery at altitude.
OXIDATIVE STRESS AND HYPERTHERMIC EXERCISE
Oxidative stress, a disruption in the oxidant-antioxidant balance, can be adaptive (acute0 or
maladaptive (chronic). Acute exercise results in transient increases in oxidative stress. However,
long-term, chronic imbalance result in maladaptive responses that can be conducive to the
development of chronic disease states (e.g., CVD)5, 6, 20. While minimization or avoidance of
chronic oxidative stress is important for overall health, implementing exercise that temporarily
shifts the oxidant-antioxidant balance is essential to stimulate beneficial exercise-induced
adaptations12,

114

. Research investigations have demonstrated that perturbations to oxidant-

antioxidant balance occurs with acute exercise; however, exercise occurs in a variety of
environmental conditions (e.g., heat, cold). The relationship between a hot environment and
elevated oxidative stress is well-established within the scientific literature115,

116

. Thus,

understanding the combination of exercise in a hyperthermic environment and how it impacts the
acute oxidative stress response to exercise is imperative.
Examination of oxidative stress requires quantification of biomarkers that provide insight
regarding cellular damage to lipids and proteins, as well as antioxidant capacity6, 9, 13, 23. McAnulty
et al. observed an elevation of F2-isoprostanes, an indicator of lipid oxidative damage, with lowintensity treadmill exercise (50% VO2max) under hyperthermic conditions (35°C, 70% Relative
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Humidity). Interestingly, F2-isoprostanes were only elevated with hyperthermic exercise, and the
shift in oxidant-antioxidant balance did not occur under normothermic conditions in the
investigation24. Further, evidence supports that the elevated oxidative stress response extends to
the post-exercise recovery period. Quindry et al. monitored the response of oxidative stress
biomarkers of lipid damage (LOOH), protein damage (PC), and antioxidant status (TEAC, FRAP)
to hyperthermic exercise and the three-hour post-exercise recovery period. A greater elevation in
oxidative stress biomarkers (LOOH, TEAC, and FRAP) was observed when compared to exercise
under normothermic conditions23. Although acute studies have supported the notion that
hyperthermic exercise increases blood oxidative stress, the impact of acclimation exercise training
remains understudied. To date, one investigation has examined the effects of four-weeks of HIIT
training on the blood oxidative stress response to exercise. Findings of the investigation indicated
an increase in the lipid damage response, while the selected marker of protein damage (PC) was
blunted26. Further investigation is necessary to understand the impact of exercise acclimation
training on the blood oxidative stress response to acute exercise.
WOODSMOKE INHALATION, EXERCISE, AND CARDIOVASCULAR HEALTH
Smoke inhalation from biomass combustion is a global public health problem due to frequent
wildfires27, 90, 92 Exposure to biomass particulate matter (PM) is associated with health dangers due
to the ability of fine particles ≤ 2.5 microns in diameter (PM2.5) to penetrate the respiratory
system28, 117. Populations affected by woodsmoke inhalation include wildland firefighters, those
residing within communities prone to wildfires, and individuals who exercise and recreate outside
during times of high exposure. Exposure to air pollution is an established risk factor for the
development of CVD due to the causal link between exposure and cardiovascular
morbidity/mortality, although the mechanisms responsible are not fully understood90, 92, 118. The
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proposed pathophysiologic mechanisms include autonomic control/dysregulation, endothelial
dysfunction, and oxidative stress29.
Assessment of autonomic control and woodsmoke exposure have focused on a non-invasive
measure of autonomic control termed heart rate variability (HRV)119. Inability to maintain high
HRV or delayed rebound following exposure to a stressor is indicative of poor cardiovascular
prognosis119-122. Investigations examining the relationship between PM exposure and reduced
HRV have produced inconsistent findings123, 124. For instance, a three hour exposure at ~ 300 µg·m3

with intermittent exercise significantly reduced HRV indices (SDNN, pNN50, RMSSD) in 14

healthy subjects one hour after cessation of the exposure123. Conversely, a two hour exposure at
500 µg·m-3with intermittent exercise and observed no changes in HRV indices (SDNN, pNN50,
RMSSD)124. Although evidence of single, acute exposures is limited, evidence of chronic and/or
ambient PM2.5 exposure indicates alterations to cardiac autonomic control in young, healthy
adults125. Additionally, evidence of autonomic dysregulation with PM exposure in susceptible
populations is well-documented within the literature29. Further research is needed to understand
the impact of recurrent, acute exposures on PM and autonomic dysregulation.
Pulse wave velocity (PWV) is a non-invasive measurement to quantify arterial stiffness and assess
atherosclerosis. PWV has been reported to correlate with endothelial dysfunction, a proposed
mechanism responsible for the association of CVD and PM exposure126. Similar to HRV,
investigations of acute woodsmoke exposures have produced equivocal results123, 127. PWV did
not increase in 16 healthy firefighters following a one hour woodsmoke exposure at 1000 µg·m-3
with intermittent exercise127. However, in contrast to these findings, PWV increased for up to 25minutes following an exposure of ~ 300 µg·m-3 combined with intermittent exercise123. The
findings of these investigations indicate PWV may respond to exposure in a duration-dependent

19

manner, specifically exposures exceeding one hour in duration123, 128. Future investigations need
to identify thresholds at which exposures become problematic (e.g., duration) for arterial stiffness
to better inform recommendations regarding this modifiable risk factor.
Oxidative stress, a significant factor in CVD development, is a proposed mechanism for the
association between PM exposure and increased risk of CVD morbidity and mortality5, 8. Oxidative
stress becomes elevated when there is a disruption in the oxidant-antioxidant balance, which
results in free radical production that exceeds antioxidant capacity5-7. Acute shifts in the oxidantantioxidant balance are required for adaptive responses; however, chronic disruptions are linked
with CVD and other diseases8-11. When examining oxidative stress, biomarkers provide
information regarding antioxidant status in addition to damage to cellular components (lipids,
proteins)6, 9, 13, 23. Clarity regarding the threshold at which acute woodsmoke PM exposures become
problematic are necessary, due to the understanding that chronic exposures elevate CVD risk. An
examination of oxidative stress following 1.5 hours of low-intensity treadmill exercise did not
produce elevations in biomarkers of protein damage (3-NT, PC), lipid damage (LOOH), or
antioxidant capacity (TEAC) with an exposure of 250 µg·m-3. However, an exposure at 500 µg·m3

elicited oxidative stress as indicated by markers of protein damage (3-NT), lipid damage (8-ISO),

and antioxidant capacity (TEAC), indicating the oxidative stress response can potentially differ
based on dose and//or duration92. Field-based examinations of wildland firefighters and exposures
under resting conditions have failed to elicit elevated oxidative stress129, 130. These collective
findings suggest that a significant shift in oxidative-antioxidant balance may be dependent on the
dose, duration of the exposure, or the accumulation of multiple exposures.
CARDIAC REHABILITATION
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CVD is the leading cause of morbidity and mortality in the United States and places a significant
burden on the health care system30, 31, 33. Estimated indirect and direct costs of CVD in the United
States was approximately $351.3 billion from 2014 to 201532. Exercise is a beneficial treatment
for individuals with diagnosed CVD. For instance, exercise programs decrease the death rate by
20-25% for individuals who suffered a myocardial infarction (MI)2. Additional exercise-related
benefits include improvement of CVD risk factors, (e.g., exercise capacity, blood pressure, lipid
panels), weight reduction, and improved quality of life37, 38. Consistent exercise is an essential
component of a CVD treatment plan due to its ability to reduce secondary events, mitigate risk
factors, lessen coronary artery disease progression, and decrease rehospitalizations1, 41, 42. Cardiac
rehabilitation is the prescribed exercise intervention to deliver health education in those who
experienced a qualifying

cardiac event, procedure, or diagnosis1,

39, 40

. Although cardiac

rehabilitation programs decrease morbidity and mortality rates and improve quality of life, these
programs are often underutilized41, 66, 67. The health benefits from regular exercise engagement
highlight the importance of increasing exercise participation.
Cardiac rehabilitation is delivered in three distinct phases: phase I (inpatient), phase II (outpatient),
and phase III (unsupervised exercise). Phase I cardiac rehabilitation focuses primarily on
assessment, mobilization, and CVD risk factor education prior to discharge from hospitalization1,
40, 131

. After an individual is discharged, phase II cardiac rehabilitation is recommended according

to clinical guidelines1, 131. Outpatient cardiac rehabilitation implements a safe, supervised exercise
program with the goal of reducing the risk of a secondary cardiac event through health education
and monitoring/improvement of CVD risk factors1. Additionally, phase II involves monitoring the
exercise response of HR, BP, heart rhythm, and symptomology before, during, and after an
exercise session1. Finally, when an individual graduates from phase II cardiac rehabilitation, they
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will then enter an unsupervised exercise program to maintain the benefits and improved quality of
life gained from the exercise intervention131. The focus of this literature review will be on phase II
outpatient cardiac rehabilitation programs.
One of the primary goals of outpatient cardiac rehabilitation is the improvement of prognostic
variables (e.g., RHR) and modifiable CVD risk factors (e.g., obesity). Risk factors include age,
family history, smoking, physical inactivity, obesity, hypertension, dyslipidemia, and diabetes1.
Of these risk factors, exercise interventions provided in cardiac rehabilitation aim to improve the
modifiable risk factors (e.g., dyslipidemia). Additionally, variables such as exercise capacity,
RHR, and BP provide significant prognostic information related to CVD. Each of the prognostic
variables and risk factors, as well as their improvement following exercise intervention, will be
discussed subsequently.
PROGNOSTIC CVD VARIABLES
Exercise Capacity
Exercise capacity is a prognostic indicator of both cardiovascular and all-cause mortality132. For
instance, a 1-MET increase in exercise capacity leads to a 12% improvement in survival132. Due
to the insight gained from the measurement of exercise capacity, testing is necessary as part of
cardiac rehabilitation1, 133. Exercise capacity, also referred to as aerobic capacity and/or exercise
tolerance, is a measure of the body’s ability to transport and extract oxygen in response to physical
stress1, 134. Measurement can be direct and/or estimated through a variety of methods, such as an
incremental exercise test (e.g., VO2max or VO2peak), submaximal exercise test (e.g., YMCA), or
additional methods that require little equipment and are suitable for field testing (e.g., 6MWT)1,
133

.
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Direct measurement of exercise capacity is the criterion measure for cardiorespiratory fitness1.
Direct measurement is obtained via open circuit spirometry to quantify maximal oxygen uptake
(VO2max), which is the product of cardiac output (Q) and arteriovenous oxygen difference (a-vO2)1,
134

. VO2max can be expressed in both absolute (L/min) and relative (ml/kg/min) units, the latter of

which is the most clinically relevant due to the ability to compare values between individuals1.
Quantification of VO2max requires an incremental exercise test that achieves volitional exhaustion
and a plateau in VO2 with increasing workload1. When this plateau is not observed, which often
does not occur in diseased populations (e.g., CVD), the measurement is referred to as VO2peak1.
Estimated aerobic capacity is determined through submaximal exercise testing or field testing,
which is ideal in situations that do not warrant maximal exercise testing, such as availability of
equipment and/or risk level of the individual1. Measurements of estimated aerobic capacity assume
correlation between direct measurements of VO2max and estimated measures1. Importantly, many
of these tests are validated; however, their ability to under or overestimate exercise capacity must
be taken into consideration1. When maximal and/or submaximal exercise testing is not possible
(e.g., equipment limitations), field testing is a sufficient method for obtaining an estimation of an
individual’s exercise capacity. For example, the six-minute walk test (6MWT) is often used within
clinical settings and involves very little equipment. The 6MWT requires participants walking as
much distance as possible within six-minutes along a flat surface135. Regardless of the method
utilized for measurement, exercise capacity can be used to evaluate the effectiveness of an exercise
program.
Improvements in exercise capacity are essential to the prevention and/or treatment of chronic
disease1, 2. Exercise capacity increases with consistent participation in aerobic endurance training
programs (e.g., running)134. Physiologically, improvements occur due to increased cardiac output
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(Q) and/or a-vO2 difference134. Cardiac output, the product of heart rate (HR) and stroke volume
(SV), increases with consistent endurance training as a result of increased SV134. Further,
participation in an exercise program increases the ability to extract oxygen from the tissues (a-vO2
difference), which also leads to increased capacity134. While improvements can be impacted by
uncontrollable factors (e.g., mitochondrial DNA), the intensity and duration of an exercise
program are controllable factors that can be modified134. At minimum, an individual needs to
accumulate 30-minutes of moderate-intensity activity most days of the week to achieve associated
health benefits1, 2.
Due the prognostic insight gained from the quantification of exercise capacity, it is vital when
evaluating the efficacy of a cardiac rehabilitation program133. Importantly, participation and
completion of cardiac rehabilitation often results in improvements in exercise capacity44-51. In a
study conducted by Lavie et al., 116 obese patients underwent graded exercise testing before and
after enrollment in a 36 session phase II cardiac rehabilitation program and significant
improvements were observed (~ 30%)48. Further, exercise capacity increased following cardiac
rehabilitation in both older (> 75 years of age) and younger (< 60 years of age) patients50. The
wealth of scientific literature supporting the improvement of exercise capacity following cardiac
rehabilitation highlights the need to improve referral and participation rates through alternative
strategies/methods.
Heart Rate
RHR is a simple, non-invasive measure that provides substantial prognostic information regarding
CVD risk, due to its association with all-cause and cardiovascular mortality136-141. Specifically,
current scientific literature demonstrates that an elevated RHR negatively impacts the occurrence
of myocardial ischemia and ventricular arrhythmias, left ventricular function, and affects the
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progression of atherosclerosis136. Thus, intentionality in exercise programming to reduce or
maintain a lower resting HR is beneficial. Further, resting HR is a valuable tool to monitor the
progress of an exercise intervention in those diagnosed with CVD. Currently, there is no scientific
consensus on an “optimal” resting HR; however, maintenance of a resting HR below 100 bpm is
considered acceptable136.
Regulation of HR occurs through the interplay of the two branches of the Autonomic Nervous
System (ANS)134, 142-144. The sympathetic nervous system (SNS) and the parasympathetic nervous
system (PNS) influence HR through their innervation of the heart at the sinoatrial (SA) node,
atrioventricular (AV) node, and the ventricles134. The SNS is the branch of the ANS responsible
for the “fight or flight” response, and it exerts its influence of HR through the cardiac accelerator
nerves, which innervate the SA node and the ventricles134, 142, 145. With stimulation, the SNS
releases epinephrine, resulting in an increase in HR and contractility of the heart itself134. The PNS,
or the “rest and digest” branch of the ANS, can decrease HR via the release of acetylcholine, which
decreases activity of the SA and AV nodes by lowering resting membrane potential134, 142. Under
resting conditions, balance between the PNS and SNS is achieved by the cardiovascular control
center134. However, with autonomic imbalance (e.g., hyperactive SNS and/or hypoactive PNS),
excessive demands are placed on the body, which are associated with pathological conditions146.
Thus, RHR can be utilized as a substantial tool in evaluation of exercise intervention efficacy.
As outlined previously, CVD treatment involves mitigation of modifiable risk factors, such as
RHR. In general, an exercise intervention focused on consistent endurance training reduces RHR,
and completion of phase II cardiac rehabilitation can reduce RHR52, 53, 64, 147-149. Beckie et al.
demonstrated a decrease in RHR following a 12-week cardiac rehabilitation program in a sample
of female patients147. Further, RHR significantly improved in a sample of 268 older patients
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following a three-month, exercise-based cardiac rehabilitation intervention148. While the
relationship between exercise training and reductions in RHR is well-established, not all exercisebased cardiac rehabilitation programs have been successful in reducing HR52, 65. An investigation
conducted by Missiri et al. demonstrated that RHR was significantly reduced following a 12-week
intervention; however, the 6-week intervention failed to produce similar results, speaking to the
importance of prescribing an intervention of sufficient length52. In further support, a 36-session
intervention requiring three sessions per week (12-week intervention) at an exercise intensity of
60-85% peak heart rate resulted in significantly lower RHR53. When examining alternative
rehabilitation approaches, resting HR is essential to determining the efficacy of the approach.
Blood Pressure
Blood pressure provides prognostic information regarding all-cause mortality and risk for
cardiovascular events150-154. Importantly, approximately 37% of Americans within the United
States are diagnosed with elevated blood pressure, or hypertension, which is an independent
modifiable risk factor for coronary artery disease that significantly increases the risk for CVD1, 155157

. Historically, hypertension was defined as a SBP over 139 mmHg, a DBP exceeding 90 mmHg,

or a combination of both measured on two or more separate occasions1, 155, 158, 159. However, the
ACC and the AHA recently redefined hypertension to a SBP exceeding 130 mmHg or a DBP
greater than 80 mmHg160, 161. Proper management of blood pressure is crucial, because a 10 mmHg
decrease in resting blood pressure is associated with 50% lower rates in all-cause mortality162.
Benefits of consistent exercise training includes prevention of hypertension and BP reduction in
those with elevated BP; thus, exercise interventions should be implemented for reduction and/or
maintenance of healthy values as part of prevention and/or treatment programs37, 157.
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Acute blood pressure regulation occurs through SNS input, which controls blood pressure through
receptors and neurohormone responses of the heart and kidneys134, 159. Short-term regulation will
only last second or minutes and is a response to transient blood pressure changes caused by
physical activity, position changes, and other acute stressors159. Short-term regulation occurs
through the baroreceptors, also referred to as pressure receptors, located within the carotid artery
and the aorta. Baroreceptors detect alterations in arterial pressure and respond accordingly134, 159.
For example, an elevation in arterial pressure results in impulses to the cardiovascular control
center, which then communicates a decrease in SNS activity is necessary134. The decrease in SNS
outflow will allow for a reduction in cardiac output and vascular resistance, ultimately resulting in
a decreased arterial pressure134. In addition to the baroreceptors, the chemoreceptors located within
the carotid bodies monitor alterations in oxygen, carbon dioxide, and hydrogen ion content in the
blood in order to respond to acute changes in arterial pressure159. If there is a drop in arterial
pressure, chemoreceptors detect decreased oxygen and elevated carbon dioxide and hydrogen ions
within arterial blood, and induce vasoconstriction to elevate pressure159. An understanding of acute
blood pressure regulation is essential to safely monitoring the exercise response during a single
exercise session; however, chronic conditions (e.g., hypertension) will be impacted by mechanisms
of long-term regulation.
Neural and hormonal mechanisms responsible for acute blood pressure regulation are unable to
maintain regulation for lengthy periods of time159. Thus, long-term control of blood pressure
occurs through regulation of extracellular fluid volume by the kidneys134, 156, 159. The kidneys will
detect an increase in renal pressure when arterial blood pressure becomes elevated, which will
signal the need for more excretion of water and sodium. Increased excretion lowers pressure and
decreases extracellular fluid volume, which reduces blood pressure to previous levels156. For those
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diagnosed with hypertension, these regulatory systems are impacted, leading to chronically
elevated blood pressure156, 159. Importantly, these mechanisms are not fully understood and seem
to be dependent on the presence of specific risk factors for hypertension (e.g., the impact of obesity
on the SNS)159.
As stated previously, management and/or mitigation of modifiable risk factors is essential within
treatment programs for CVD1, 38, 160. Importantly, BP is one of the most significant modifiable risk
factors for CVD and it is well established that consistent exercise improves resting BP38, 155, 157, 160,
163, 164

. For instance, ACSM recommends endurance training for a minimum of 30-minutes per day

to decrease BP in those with diagnosed hypertension1, 165, 166. Specifically, regular aerobic exercise
programming can result in a 5-10 mmHg decrease in both SBP and DBP

155

. Thus, exercise

interventions are beneficial for risk factor reduction, due to the importance of BP control for
prevention of secondary events167. A recent investigation examined the impact of phase II cardiac
rehabilitation on resting BP and the results indicated that both SBP and DBP were reduced by
approximately 1 mmHg following rehabilitation38. Importantly, the Quindry et al. study is not
alone in establishing the benefits of phase II cardiac rehabilitation on resting BP. Several
investigations have demonstrated similar improvements in both SBP and DBP following cardiac
rehabilitation168-171; however, results regarding BP and cardiac rehabilitation remain equivocal
with some investigations demonstrating no improvements172-175.
CVD RISK FACTORS
Dyslipidemia
Quantification of an individual’s lipid profile is essential for CVD risk factor assessment 1. Lipids
are ingested (exogenous) or stored (endogenous) within the body, and transportation of these lipids
is performed by various types of lipoproteins that differ in function and size. Lipoproteins falls
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into the following categories: high-density lipoproteins (HDL-C), low-density lipoproteins (LDLC), intermediate-density lipoproteins (IDL), very-low density lipoproteins (VLDL), and
chylomicrons. Transportation of endogenous lipids from one organ to another is performed by the
lipoproteins HDL, LDL, IDL, and VLDL, while exogenous lipids are transported from the
intestines by chylomicrons, which allows them to enter circulation144.
Most lipoproteins (chylomicrons, LDL, IDL, and VDL) promote formation of plaque within
arteries; thus, elevated levels in circulation are associated with an increased risk of CVD176.
Specifically, LDL-C causes turbulent blood flow that damages the endothelium, enters the arterial
wall to become oxidized and initiate an inflammatory response, and forms atherosclerotic
plaque144. Formation of atherosclerotic plaque impairs vasodilation, decreases arterial diameter,
and causes a thrombus if the plaque ruptures144. While elevated LDL-C negatively impacts CVD
risk, HDL-C exhibits a protective property due to its role in the removal of cholesterol molecules
from the peripheral tissues. For this reason, HDL is positively associated with cardiovascular
health and is considered a negative risk factor in the CVD risk stratification process1, 177.
Dyslipidemia, or lipid dysregulation, is characterized by elevated concentrations of lipid profile
markers within the blood, which increases an individual’s risk for CVD as described above1, 177181

. In addition to CVD, dyslipidemia is associated with atherosclerosis, stroke, cancer, diabetes

and peripheral vascular disease176, 182. Dyslipidemia can be diagnosed through the quantification
of TC, LDL-C, and/or HDL-C. Based on the guidelines provided by the ACSM, a TC > 200 mg·dL1

, LDL-C ≥ 130 mg·dL-1, or an HDL-C < 40 mg·dL-1 indicates that an individual has dyslipidemia1.

Due to the association between elevated lipid profile markers and CVD risk, improvements in
these markers are vital to an individual’s health. Improvements are characterized by a decrease of
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TC or LDL-C. Additionally, due to the protective nature of HDL-C, an increase ≥ 60 mg/dL would
be ideal1, 182.
Dyslipidemia is an important modifiable risk factor that can be improved with lifestyle
adjustments1,

183

. Generally, favorable changes in lipid panel markers occur with consistent

exercise training1, 183. A minimum of 12-weeks of aerobic training with a volume of 1000-1200
kcals·wk-1 significantly increases HDL-C144. Phase II cardiac rehabilitation can increase HDL-C;
however, improvements in TC and LDL remain equivocal within the literature46, 48-50, 56, 57, 59-65, 184186

. For instance, Lavie et al. examined 588 obese patients following phase II cardiac rehabilitation

and observed improvements in HDL-C; but TC and LDL-C remained unchanged49. Improvements
in HDL-C with rehabilitation occur independent of age and exercise capacity56,

63-65

. An

investigation of 163 patients with high baseline exercise capacity (≥ 6 METS) demonstrated a
significant increase in HDL-C and a reduction in TG following rehabilitation63. Further, a
comparison between younger (< 65 years) and older (≥ 65 years) patients demonstrated no
differences in HDL-C responses to cardiac rehabilitation programs56.
Although lipid panel improvements are not impacted by age and/or exercise capacity, evidence of
sex-dependent differences in response to cardiac rehabilitation are present in the literature. An
investigation examined 83 females and 375 males following phase II cardiac rehabilitation
determined that females did not improve HDL-C, TC, or TG; however, male subjects experienced
improvements in all three lipid panel markers74. Further, Sadeghi et al. examined 464 non-obese
males and 121 non-obese females following 24 cardiac rehabilitation sessions and HDL-C was not
improved in the female subjects187. Potential explanations for differences in lipid management
following cardiac rehabilitation are medication adherence and/or the effects of menopause on lipid
metabolism188-192.
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Diabetes
Evaluation of blood glucose management is vital in the assessment of CVD risk1. Type 2 diabetes
mellitus (DM) is a risk factor, and approximately 22% of CVD patients enrolled in cardiac
rehabilitation have been diagnosed1, 188, 193. Importantly, ongoing DM leads to atherosclerosis,
increased oxidative stress, endothelial dysfunction, and poor peripheral perfusion144. DM is
characterized by decreased insulin sensitivity and secretion of insulin from pancreatic beta cells1,
144, 155

. With a reduction in insulin sensitivity, glucose uptake becomes impaired; thus, leading to

hyperglycemia. Additionally, the progression of DM decreases insulin secretion, further reducing
uptake and the ability to maintain an optimal blood glucose concentration144, 194. Blood glucose
maintenance is evaluated through the quantification of FBG and HbA1c. When dysregulation of
blood glucose maintenance occurs, it presents as an elevated FBG and/or HbA1C1, 144. Diagnostic
criteria for DM include a FBG ≥ 126 mg·dL-1 and/or an HbA1C ≥ 6.5%1.
Regular physical activity is beneficial for both the treatment of blood glucose dysregulation and a
reduction in risk of DM development195-200. The management of DM typically involves a
combination of lifestyle management (e.g., exercise and/or diet) and medications1, 155. Consistent
exercise training is essential in the treatment of DM because it consistently reduces CVD risk144.
The acute effects of an exercise session on blood glucose management include increased glucose
uptake through insulin-independent pathways and improvement of insulin sensitivity that lasts up
to 72-hours after exercise cessation144, 201. While both aerobic and resistance modalities improve
insulin sensitivity in those with DM, a combination of both training methods is considered the best
method for improving blood glucose management201-211.
Due to the importance of consistent physical activity treatment, quantification of FBG and HbA1c
are essential in monitoring the efficacy of an exercise program for those diagnosed with DM.
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Importantly, participation in cardiac rehabilitation does not improve FBG except in those with
diagnosed DM49, 58, 184, 185, 195. For instance, FBG did not improve in 235 obese or 353 non-obese
individuals following completion of 36 exercise sessions within a cardiac rehabilitation program49.
However, the Health Risk Factor Exercise Training and Gender (HERITAGE) Family Study
demonstrated modest FBG improvements in patients with diagnosed metabolic syndrome212
Notably, negative findings regarding FBG with exercise training are not limited to cardiac
rehabilitation settings, because exercise training often fails to reduce FBG in apparently healthy
subjects213. Elevated FBG is associated with increased CVD risk; however, levels are influenced
by meal timing, obesity, age, and neuroendocrine factors213-216. Thus, FBG should be examined in
combination with other biomarkers and/or tests to assess risk for DM and/or CVD development.
HbA1c, a long-term marker in the evaluation of diabetes and blood glucose management, measures
glycated hemoglobin within red blood cells217. Due to the life cycle of red blood cells (~ 120 days),
HbA1c is considered an average of blood glucose levels over a three-month period218. HbA1c is
associated with improved survival, which highlights the necessity for monitoring and managing
HbA1c in cardiac rehabilitation patients219. Improvements in HbA1c with exercise training have
been observed, although results remain mixed49,

185, 211, 220-223

. An investigation comparing

intensive (≥ 2 days/week and step count ≥ 9,000/day) and standard cardiac rehabilitation (≥ 1
day/week and step count ≥ 6,000/day) only observed improvements in the intensive group; thus,
indicating that HbA1c improvements are likely attributed to the exercise dose224.
Obesity
Obesity has become a global public health concern with more than 1 billion overweight adults and
300 million obese adults worldwide225. Specifically, within the United States, more than 78 million
adults met the obesity classification between 2011 and 2012226. Obesity is a growing problem
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within the United States, with medical costs as high as $147 billion in 2008227. Importantly, obesity
is associated with the acceleration of atherosclerosis, related to several CVD risk factors, such as
hypertension and dyslipidemia, and increases CVD mortality risk225, 228-231. For instance, for each
1-unit increase in BMI, SBP increased by 1.04 mmHg in females and 1.16 mmHg in males

225

.

Due to the significant health-care costs associated with obesity and increased risk for CVD
mortality, it is essential that monitoring and reducing body weight is incorporated into treatment
programs. When implementing treatment programs/resources, it is important to consider who is
most susceptible to obesity, because there is evidence of greater prevalence in those with lower
incomes and less education227.
Obesity can be quantified through a variety of methods, such as the measurement of percent body
fat (PBF), waist-to-hip ratio (WHR), and BMI. While specialized equipment and training is
necessary for the quantification of PBF, both BMI and WHR are simple, accessible measures that
can provide body weight and CVD risk assessments. BMI is determined by dividing an
individual’s weight in kilograms by height in meters squared (BMI = Weight [kg] / Height [m2])
1

. An individual is classified as overweight when BMI falls between 25 kg/m2 and 29.9 kg/m2, and

obese when BMI is ≥ 30 kg/m2 1. Given the relationship between obesity and CVD risk,
relationships between high BMI and mortality from CVD are also present. Individuals classified
as overweight experience 60% higher risk in mortality225, 232. Additionally, WHR is quantified by
dividing the circumference of the waist by the circumference of the hips1. Information regarding
the distribution of body weight, presence of abdominal fat, and health risk can be gained from
quantification of WHR1, 233-236.
Due to the relationship between BMI and CVD mortality risk, it is evident that utilizing
measurement of BMI provides important information regarding the efficacy of cardiac
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rehabilitation programs. In general, BMI can decrease with participation in phase II cardiac
rehabilitation46, 48-50, 56, 57, 63-65. Further, observed improvements in BMI following 3-months of
cardiac rehabilitation do not appear to be limited by the age of the patient50, 56, 65. Lavie et al.
examined 92 elderly patients (≥ 65 years) and 182 younger patients (< 65 years) and identified a
significant reduction in BMI in both groups following phase II cardiac rehabilitation, indicating
the efficacy of exercise training in the reduction of BMI. Importantly, Lavie et al. observed no
differences between the younger and elderly patients in their ability to improve BMI with
rehabilitation; thus, elderly patients can benefit from participation regardless of age65. Also,
improvements in BMI are not impacted by an individual’s baseline exercise capacity. Lavie et al.
demonstrated significant reductions in BMI following phase II cardiac rehabilitation in cardiac
patients with higher baseline exercise capacity63. Although age and/or exercise capacity do not
limit an individual’s ability to decrease BMI, there is evidence to support differences based on sex
and/or BMI classification49, 74 While there are situations in which BMI does not decrease following
intervention (e.g., non-obese individuals), BMI remains a significant, essential variable to monitor
progress of the intervention in addition to CVD risk assessment.
DEPRESSION
Depression, a common comorbidity in those suffering CVD, is associated with increased risk for
CVD development237. Up to 40% of cardiac patients experience depression and/or anxiety
following cardiac events238. Importantly, depression screening is vital, because it provides
prognostic information, and depressive symptoms make adherence to lifestyle modifications (e.g.,
physical activity) even more challenging in CVD patients239, 240. Often, individuals experiencing
depression do not believe in the efficacy of treatments, which leads to non-compliance and
significantly impacts treatment outcomes155. Thus, depression can present challenges in achieving

34

the well-established, evidence-based benefits of a cardiac rehabilitation program. Further, the
impact of depression on outcomes extends beyond the 12-week program. Mortality increases fourfold in depressed patients following cardiac rehabilitation compared to nondepressed patients,
highlighting the importance of monitoring depression throughout the rehabilitation program186.
Depression can be examined utilizing the 9-item Patient Health Questionnaire (PHQ9), which is
an assessment tool for the detection of depression and determination of severity241. The PHQ9
questionnaire asks patients to rate 9 depressive symptoms on a scale of 0-3, with 0 representing
“not at all” and 3 expressing the patient experienced the symptom “nearly every day.” The PHQscore can range from 0-27. An individual is considered to have severe depression if they rate at
least 5 of the symptoms as a 2 (“more than half the days”) or higher (“nearly every day”). The
PHQ9 is often administered at enrollment and completion of cardiac rehabilitation to assess the
effects of the program on depressive symptoms.
Exercise training is a well-established method for reducing depressive symptoms; however, the
scientific literature on cardiac rehabilitation has produced mixed results155, 242-247. For instance, an
examination of 93 patients did not result in PHQ9 improvements following a six-month, exercisebased cardiac rehabilitation program246. However, Gardiner at al. examined 79 participants with
improvements in PHQ9 scores following a six-week, multi-disciplinary cardiac rehabilitation
program that included group therapy, risk factor education, prescribed exercise, nutritional
counseling, and stress management245. These findings are suggestive that a tailored, holistic
approach to cardiac rehabilitation is more beneficial for improvements in depressive symptoms. A
meta-analysis conducted by Gellis et al. further supports the notion that interventions involving
additional content (e.g., nutrition and/or psychosocial intervention) could produce more favorable
results in depressive symptoms. Additionally, patients with mild or moderate depressive symptoms
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are less likely to exhibit significant improvements, and the interventions must be of sufficient
length244.
Females experience many barriers to entry in cardiac rehabilitation programs. Upon entry into
cardiac rehabilitation, female patients are more likely to present with severe depressive symptoms
compared to male counterparts (92% vs. 65%)242. Not only are females more likely to present with
depression, but depressive symptoms and non-completion of cardiac rehabilitation programs are
associated248. Although females are more likely to present with symptoms of depression, females
typically experience a reduction in depressive symptoms following cardiac rehabilitation, and have
even been shown to experience greater improvements when compared to their male
counterparts249. Due to the well-established benefits of cardiac rehabilitation, it is essential to
increase female participation and adherence, which requires tailoring programs to the needs of
female patients250.
TRADITIONAL VS. HOME-BASED CARDIAC REHABILITATION
Commonly reported barriers to enrollment in TCR programs can be overcome through the
implementation of alternative rehabilitation methods. HBCR programs that include telehealth and
educational components are one proposed alternative to overcome barriers experienced by CVD
patients42,

68, 81, 82

. Importantly, the goals of cardiac rehabilitation include improvement of

prognostic variables, CVD risk factor reduction, and depression. Due to the emphasis of these
goals in TCR, evaluation of these variables must be utilized to determine the effectiveness of
HBCR programs for cardiac rehabilitation patients. To review the efficacy of HBCR, current
evidence on the programs and risk factor reduction is discussed subsequently.
Prognostic Variables
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Both TCR and HBCR improve exercise capacity251-275. Based on current evidence, improvements
are likely dependent on the length of the intervention and/or exercise dose. Intervention lengths of
8-weeks, 12-weeks, and 6-months have consistently demonstrated improvements; however,
current evidence supporting interventions less than 8-weeks in duration remain equivocal251-253, 256,
257

. Oerklid et al. examined the effects of a 6-week intervention (60-minutes sessions, 2 d·wk-1)

and observed no improvements in exercise capacity265. Importantly, results of an intervention are
likely impacted by the prescribed exercise dose. For instance, Scalvini et al. examined a 4-week
intervention and observed improvements in exercise capacity with 140 minutes of exercise per day
(100 minutes in the morning and 40 minutes in the afternoon), which resulted in significant
exercise capacity improvements in both the TCR and HBCR groups268. Overall, cardiac
rehabilitation interventions of sufficient duration and dose consistently improve exercise capacity.
Comparisons of HBCR and TR are equivocal regarding which method is superior. Most
investigations reveal no differences between rehabilitation methods. Two investigations have
observed greater improvements in exercise capacity following HBCR; however, neither study
quantified the exercise dose for between-group comparisons.
Investigations of RHR following cardiac rehabilitation interventions have produced mixed results,
with investigations reporting no RHR changes following rehabilitation, others reporting decreases,
and one study reporting improvements only following HBCR251, 253, 270, 271, 274, 275. Aamot et al.
examined RHR following a 12-week intervention (2 d·wk-1, interval training with uphill walking
or jogging) and RHR decreased only in the HBCR group regardless of the lower exercise session
attendance rate251. Further, Arthur et al. observed a significant reduction in RHR in both TCR and
HBCR patients following a 6-month intervention (3 d·wk-1)253. Although investigations have
observed improvements, not all interventions have been successful in reducing RHR. For instance,
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a 6-week intervention (2 d·wk-1, 6-10 and 11-13 Borg Scale) did not improve RHR in either TCR
or HBCR groups274. Additionally, investigations involving a 12-week intervention (30 min, ≥ 3
d·wk-1) and a 6-month intervention (endurance and resistance training) monitored by a smartphone guided training system produced no differences in RHR in either TCR or HBCR271, 275.
Importantly, there is no evidence of differences between TCR and HBCR for RHR reduction.
Randomized-controlled trials examining the effects of TCR and HBCR on resting SBP and DBP
consistently demonstrated no improvements in either marker of hypertension263, 265, 270, 274, 275.
Shagufta et al. examined a 4-week intervention of aerobic exercise (3 d·wk-1, 4-6 Borg Scale) on
resting SBP and DBP. No improvements in BP occurred and there were no differences between
TCR and HBCR groups270. Further, post myocardial infarction patients experienced no BP
improvements following a 6-week intervention and a 6-month maintenance program in TCR (3
d·wk-1 supervised, total of 5 d·wk-1) and HBCR (5 d·wk-1). Even though HBCR self-selected into
more exercise sessions, neither group experienced improvements, and no differences between
groups were observed274. A 6-week intervention in which TCR patients (60-minutes of exercise 2
d·wk-1) and HBCR patients (30-minutes of exercise 6 d·wk-1) resulted in no BP improvements in
either group. Together, the results of the two aforementioned studies indicate the greater dose of
exercise within HBCR patients did not improve BP outcomes265. Further, interventions of greater
length have failed to demonstrate improvements in BP outcomes251, 253, 254, 261, 262. A sample of 55
patients underwent a 12-week intervention with aerobic exercise (3 d·wk-1) that did not result in
BP improvements with TCR or HBCR275. Additionally, an investigation of the effects of a 12week intervention with a greater exercise dose (3 d·wk-1 supervised, 5 d·wk-1 total), in which
participants received real-time feedback from a remote exercise specialist, resulted in no BP
improvements in either TCR or HBCR263. Several investigations of interventions lasting 12-weeks
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and 6-months further support that HBCR does not improve BP outcomes251, 253, 254, 261, 262. BP
improvements following cardiac rehabilitation have shown improvement; however, the reductions
in BP were modest (~ 1 mmHg), and literature remains equivocal with most investigations failing
to decrease BP38, 168-175
CVD Risk Factors
Dyslipidemia, a modifiable CVD risk factor, can be improved with consistent exercise training1,
183

. Generally, cardiac rehabilitation can increase HDL-C in those with dyslipidemia, while

improvements in TC and LDL-C remain equivocal within the literature46, 48-50, 56, 57, 59-65, 184-186.
Investigations comparing TCR and HBCR have produced mixed results; however, most of the
evidence supports no differences in efficacy between TCR and HBCR regarding lipid panel
markers170, 254, 256, 259, 263, 264, 271, 274, 275. Importantly, negative findings are not dependent on the
intervention length as demonstrated by investigations observing no lipid panel improvements
following 6-week, 9-week, 12-week, or 6-month interventions254, 256, 263, 265, 271. For instance, an
intervention as short as 6-weeks (TCR: 2 days·wk-1, 60-min, HBCR: 6 days·wk-1, 30-min)
observed no changes in TC, HDL-C, or LDL-C in either TCR or HBCR 265. Additionally, a typical
12-week intervention (150 min·wk-1, 70-80% HRR) did not improve TC, HDL-C, and LDL-C;
however, approximately half of the patients within the sample did not present with abnormal lipid
panels at baseline254. Cardiac rehabilitation interventions with success improving lipid panel
markers often occur in patients with diagnosed dyslipidemia. For example, patients with low HDLC and high TC at the time of enrollment in the BRUM study significantly decreased TC and
increased HDL-C in TCR and HBCR259. Further, lifestyle and dietary considerations are
confounding variables when considering the ability of cardiac rehabilitation to improve lipid
panels. Moholdt et al. observed no improvements in lipid panels (HDL-C, TG, TC) with HBCR;
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however, HDL-C was improved in the TCR group. Differences were attributed to dietary
counseling and cooking classes that were only provided to the TCR patients264. Further, Lee et al.
compared TCR and HBCR and observed improvements in HDL-C and TC only in the TCR group,
which was attributed to greater dietary reinforcement with on-site rehabilitation170. The impact of
external variables lipid panel biomarkers (e.g., diet) highlight the necessity of holistic approaches
to cardiac rehabilitation (e.g., dietary counseling).
Diabetes, a CVD risk factor, is monitored by measurement of FBG and HbA1c, and neither
variable is impacted by TCR or HBCR254,

256, 263, 264, 267, 271

. A 6-week cardiac rehabilitation

intervention (3 days·wk-1, 30-min, 70-80% HRR) did not decrease FBG or HbA1c levels with
TCR (FBG: 95 ± 14 vs. 104 ± 28 mg·dL-1, HbA1c: 5.6 ± 1.1 vs. 5.8 ± 1.3) or HBCR (FBG: 110 ±
29 vs. 107 ± 15 mg·dL-1, HbA1c: 6.1 ± 1.2 vs. 6.2 ± 1.4)256. Investigations have examined various
intervention lengths (e.g., 12-weeks, 6-months, etc.) and modalities (e.g., aerobic interval training)
and observed no effects of the interventions on FBG264, 271. For instance, Avila et al. assessed the
effects of a typical 12-week intervention (150 min·wk-1, 70-80% HRR) on FBG and observed no
differences between TCR (5.96 ± 1.0 vs. 5.94 ± 1.1 mmol·L-1) or HBCR (5.62 ± 0.5 vs. 5.36 ±
0.4 mmol·L-1)254. Importantly, biomarkers assessing glucose control can be impacted by
confounding variables, such as diet, age, obesity, neuroendocrine factors, and lack of habitual
physical activity213-216. For example, an investigation observed a significant increase in HbA1c
following cardiac rehabilitation (TCR: 5.3 ± 0.4 vs. 5.5 ± 0.3, HBCR: 5.6 ± 0.7 vs. 5.9 ± 0.7),
which was attributed to lifestyle choices that impacted insulin sensitivity264. Additionally, positive
results of cardiac rehabilitation on FBG have most often been in those diagnosed with diabetes;
thus, it appears that cardiac rehabilitation does not impact biomarkers of glucose control in those
with normal FBG and HbA1c levels58.
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Comparisons of TCR and HBCR have demonstrated no differences in BMI improvements254, 256,
263, 265, 271-273, 275

. Importantly, individuals who are not classified as obese (≥ 30 kg/m2) are not likely

to reduce BMI with cardiac rehabilitation, and most investigations examined non-obese
individuals49. For instance, 75 non-obese patients (TCR: n = 39, BMI= 27.9 ± 4, HBCR: n = 36,
BMI = 27.7 ± 5) did not decrease BMI following 6-weeks of TCR (60-minutes, 2 days·wk-1) or
HBCR (30 min·dy-1, 6 days·wk-1)265. Further, Bravo-Escobar et al. observed no differences in BMI
following TCR (Pre: 29.3 ± 3.6, Post: 29.1 ± 3.8) and HBCR (Pre: 28.6 ± 3.8, Post: 29.1 ± 4.3)
with an 8-week intervention (TCR: 3 days·wk-1, HBCR: 1 days·wk-1 supervised) that required 30minutes of aerobic training at 70-80% of HRR256. Importantly, these findings are not limited to
short-term interventions (< 12-weeks). Avilla et al. compared the effects of 12-weeks of TCR (3
days·wk-1, 45-min, 70-80% HRR) and HBCR (150 min·wk-1, 70-80% HRR) on BMI and no
improvements occurred with either TCR (Pre: 27.8 ± 4, Post: 27.8 ± 4) or HBCR (Pre: 26.6 ± 2.5,
Post: 26.9 ± 2.6)254. Other investigations involving a 12-week intervention with ≥ 3 days·wk-1 of
exercise also failed to improve BMI, and long-term interventions (> 12-weeks) do not appear to
impact BMI263,

275

. Skobel et al. determined that BMI was not reduced following a 6-month

intervention with the use of a guided exercise system that included resistance and endurance
training271. Additionally, Smith et al. examined a 6-month intervention (5 days·wk-1, 40-min
aerobic exercise) and determined that BMI did not decrease with TCR (Pre: 28.3 ± 5, Post: 28.7 ±
5) or HBCR (Pre: 26.8 ± 3, Post: 26.9 ± 3), and patients still had no reduced BMI at the 1-year or
6-year follow-up appointments272, 273. Investigations have observed significant decreases in BMI
with both TCR and HBCR; however, differences were modest and likely not clinically relevant262,
267

.

Depression
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Although exercise training is a well-established method for reducing symptoms of depression, the
impact of cardiac rehabilitation on depressive symptoms remains unclear and investigations
comparing outcomes of TCR and HBCR on depressive symptoms are limited257, 259, 262, 274. Kraal
et al. examined the effects of a 12-week intervention (45-60 min, 70-85% HRmax, 2 d·wk-1) and
observed no improvements in PHQ9 depression scores in TCR (Pre: 3.09 ± 3.07, Post: 2.89 ± 2.99)
or HBCR (Pre: 3.16 ± 3.73, Post: 2.21 ± 3.00); however, the patients did not present with
depressive symptoms prior to the intervention262. Further, an investigation examining EQ-5D
scores following a cardiac rehabilitation intervention (TCR: 9-24 sessions, 35-40 minutes, at 6575% HRmax, HBCR: 15 min·dy-1) observed no improvements at the 12-month follow-up in TCR
(Pre: 4.53 ± 3.13, Post: 4.73 ± 3.6) or HBCR (4.85 ± 3.3, Post: 4.61 ± 4.0259. Interestingly,
improvements in depressive symptoms do not appear to be limited by baseline scores. Varnfield
et al. determined that six-week TCR (2 d·wk-1, circuit-based exercise) and HBCR (30 min·dy-1,
moderate-intensity walking) interventions were effective at reducing depression scores in a sample
of patients that presented with normal scores at baseline274. Although the literature is mixed
regarding the ability of cardiac rehabilitation to reduce depression scores, it is evident that there
are no differences in outcomes between TCR and HBCR.
RATIONALE
CVD is the leading cause of morbidity and mortality within the United States and it places a
significant financial burden on the healthcare system30-33. The benefits of exercise in CVD
treatment are well-established within the scientific literature; thus, cardiac rehabilitation programs
are prescribed to qualifying individuals to provide exercise interventions and health education1, 2.
Commonly reported barriers to cardiac rehabilitation enrollment or completion are lack of time,
distance to health-care facility, transportation issues, and difficulties due to comorbidities42, 68-71,
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81-83

. HBCR is potential alternative for patients experiencing barriers to enrollment. To date, HBCR

have been extensively researched within well-controlled clinical trials. However, research-based
supervision could influence outcomes due to the established relationship between supervised
exercise programs and increased adherence276.Therefore, the proposed investigation will take an
organic, observational approach to a retrospective analysis comparing TCR and HBCR on exercise
capacity (peak METs), RHR, SBP, DBP, BMI, and PHQ-9 scores.
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Chapter III: Methodology
Patient Data Collection
Data were collected from the St. Patrick’s Hospital data registry for all patients enrolled in the
cardiac rehabilitation program between the dates of March 15th, 2020 (the onset of pandemicrelated closures) and December 31st, 2021. For an additional analysis, patients were classified as
“rural” (> 30-minute commute) or “greater Missoula area” (≤ 30-minute commute) as determined
by zip code68. A data use agreement was completed by the Cardioprotection Laboratory and the
International Heart Institute of St. Patrick’s Hospital/Providence Health Care System in
collaboration with University of Montana. An exemption letter was issued by The University of
Montana Institutional Review Board for the use of deidentified cardiac rehabilitation data from the
registry.
Measurement of Exercise Capacity
All patients underwent a symptom-limited treadmill-based exercise test at the time of program
enrollment for the quantification of exercise capacity utilizing the modified Naughton protocol1.
The incremental exercise test required an elevation in workload at the completion of each 2-minute
stage by increasing treadmill grade and/or speed. Importantly, each stage required no more than a
1 MET (3.5 ml/kg/min) increase. Exercise testing concluded when the individual reached
volitional fatigue or achieved a workload of 5.4 METs. Throughout the test, participants were
fitted with an electrocardiogram to monitor heart rate and rhythm, and blood pressure was
measured throughout each stage of the test by a trained hospital staff member. In addition to the
graded exercise test, a six-minute walk test (6MWT) was conducted at the onset and conclusion of
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the rehabilitation program for assessment of exercise capacity. Participants were instructed to walk
the longest distance possible in a six-minute period along a flat surface135.
Collection of Cardiovascular Vital Signs
Resting systolic blood pressure (SBP) and diastolic blood pressure (DBP) were measured with the
patient in a seated position. Measurements were obtained by trained hospital staff members
employed by the International Heart Institute cardiac rehabilitation program. SBP and DBP values
were measured prior to the first prescribed exercise session (PRE) and the last prescribed exercise
session (POST). Additionally, resting heart rate (RHR) was recorded prior to the first prescribed
exercise session and the last session as measured by an electrocardiogram.
Collection of Cardiovascular Disease Risk Factors
Metabolic panels were conducted to examine total cholesterol (TC), triglycerides (TG) low-density
lipoproteins (LDL-C), high-density lipoproteins (HDL-C), fasting blood glucose (FBG), and
glycated hemoglobin (HbA1c) to examine risk factor modification. Blood samples were collected
via venipuncture through an antecubital vein by a trained phlebotomist. On the date of enrollment
in the cardiac rehabilitation program, the patient’s height and weight as collected by trained
hospital staff employed with the International Heart Institute cardiac rehabilitation program. Body
mass index was later calculated by dividing the patient’s weight by height (BMI = kg/m2).
Depression Questionnaire
The 9-item Patient Health Questionnaire (PHQ9) is a validated assessment tool for both detection
of depression and determination of severity241. The PHQ9 questionnaire asks patients to rate 9
depressive symptoms on a scale of 0-3, with 0 representing “not at all” and 3 expressing the patient
experienced the symptom “nearly every day.” The PHQ9 score can range from 0-27. An individual
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is considered to have severe depression if they rate at least 5 of the symptoms as a 2 (“more than
half the days”) or higher (“nearly every day”). For the current investigation, the PHQ9 was
administered to patients at the time of their enrollment in the cardiac rehabilitation program (PRE)
and upon the completion of their prescribed sessions (POST) to assess the impact of cardiac
rehabilitation on symptoms of depression.
Statistical Analyses
Repeated Measures Analysis of Variance (RMANOVA) were used to compare PRE and POST
data for exercise capacity (peak METs and 6MWT distance), RHR, resting SBP and DBP,
metabolic panel (TC, LDL-C, HDL-C, TG, FBG, HbA1c), BMI and PHQ9 outcomes between
traditional and home-based cardiac rehabilitation programs, rural and Greater Missoula area
residents, and to examine sex-dependent differences between male and female patients. Statistical
significance was set to an alpha ≤ 0.05, a priori. Data are reported as mean ± SD. All data analysis
was conducted utilizing the SPSS (Version 26.0) software package (IBM).
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Chapter IV: Blood Oxidative Stress and Post-exercise Recovery are Unaffected by
Hypobaric and Hypoxic Environments
ABSTRACT
Hypobaria and hypoxia exert independent effects on oxidative stress during exercise, while their
combined effects on the post-exercise recovery period remain unclear. The purpose of the study
was to examine the recovery period during lab-simulated hypoxic and hypobaric conditions
following exercise-induced oxidative stress. Participants (n=13) performed 60-minutes of cycling
(70% watts max) in a normobaric normoxic environment followed by a four-hour recovery under
three conditions; 1000m normobaric normoxia (NN, 675mmHg), 4400m normobaric hypoxia
(NH, 675mmHg), or 4400m hypobaric hypoxia (HH, 440mmHg). Blood samples were collected
at Pre, Post, 2-Hours (2-HR), and 4-Hours (4-HR) post-exercise and analyzed for a potential
increase of biochemical products by the reaction of proteins (protein carbonyls, PC; 3nitrotyrosines, 3NT) lipids (lipid hydroperoxides, LOOH; 8-isoprostanes, 8-ISO), and antioxidant
capacity (FRAP, TEAC). Gene transcripts (EPAS, HMOX1, SOD2, NFE2L2) were quantified by
qRT-PCR from muscle biopsies taken Pre and Post exercise. Hypoxia and hypobaria had no effect
throughout recovery. Post-exercise TEAC (p=0.041), FRAP (p=0.013), and 8-ISO (p=0.044)
increased, while PC (p=0.002) and 3-NT (p=0.032) were decreased. LOOH was lower in Post
(p=0.018) NH trial samples. Exercise-dependent increases occurred in NFE2L2 (p=0.003),
HMXO1 (p<0.001), SOD2 (p=0.046), and EPAS (p=0.038). Exercise recovery under conditions
of NH and HH did not impact blood oxidative stress or redox-sensitive gene transcripts.

47

INTRODUCTION
Acute exercise is known to cause perturbations in redox balance and commonly results in a
transient blood oxidative stress response in both laboratory and field-based settings9,

11-13

.

Although chronic, long-term oxidative stress can negatively impact physical health, previous
research suggests temporary, acute changes in redox balance that occur during exercise and the
post-exercise recovery period could be necessary to develop exercise adaptations12. Oxidative
stress results from both exercise stimuli and various environmental conditions16, 19, 95, 112. Even
under resting conditions, high altitude can alter an oxidative stress response in ways that are
magnified during exercise18, 113, 277. Further, the acute oxidative stress can be blunted following
exercise under normobaric normoxic conditions when the post-exercise period when recovery
occurs at altitude14, 15, 17. Previous investigations have produced discrepant findings, with some
results showing a blunting of oxidative stress and others showing no effect of environmental
conditions, which reveals that responses to exercise and environmental stressors are more dynamic
than previously thought93. With many recreationally active individuals self-selecting into exercise
under a host of variable environmental conditions, it is important to gain new insights into the
effects of hypoxia and hypobaria on blood oxidative stress responses during the subsequent
recovery period. Prior work indicates that the experimental parameters of a particular study are
essential in delineating the independent and combined effects of environmental hypoxia and
hypobaria during the post-exercise recovery period. Moreover, the variations in the environment
can influence oxidative stress biomarkers during and following an acute bout of exercise14-17.
Given the need to control these experimental variables, many research groups interested in this
topic have opted for investigations in tightly controlled laboratory settings. Case in point, previous
field-based research suggests that acute exercise under hypoxic conditions can result in an
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enhanced oxidative stress response as compared to normoxic exercise16. However, conclusions
from these studies are complicated by the independent observations that hypoxic exercise elevates
the relative intensity of a given workload, and may therefore reflect the fact that higher intensity
exercise is merely associated with magnified oxidative stress responses9, 278-280. Thus, while fieldbased studies have paved the way for altitude-based studies of work physiology, well-controlled
laboratory studies were needed to delineate the independent effects of hypoxia on the post-exercise
recovery period. For example, recent laboratory studies demonstrate that exercise recovery
occurring under altitude-simulated hypoxic conditions blunt the oxidative stress response15.
However, a gap in knowledge remains in regard to the independent impact of hypobaric conditions
on blood oxidative stress during the post-exercise recovery period. Therefore, the purpose of the
current study was to examine the independent effects of hypobaria and hypoxia on post-exercise
blood oxidative responses during the recovery period. A strategic panel of blood oxidative stress
biomarkers was selected to quantify lipid damage (lipid hydroperoxides, LOOH; 8-isopsotane, 8ISO), protein damage (protein carbonyls, PC; 3-nitrotyrosine, 3-NT), and antioxidative status
(Trolox equivalent antioxidant capacity, TEAC; Ferric reducing ability of plasma, FRAP).
Additionally, the redox-sensitive gene transcripts EPAS, HMOX1, SOD2, and NFE2L2 were
examined from vastus lateralis biopsies in order to examine potential redox changes within muscle
tissue. We hypothesized that both hypoxic and hypobaric conditions would result in a blunting of
the oxidative stress response during the post-exercise recovery period.
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METHODS
Participants
Informed consent for this investigation was obtained via the Institutional Review Board (IRB) and
the United States Army Medical Research and Development Command (USAMRMC) Human
Research Protections Office (HRPO). Participants granted written consent prior to study initiation.
Recreationally trained male (n = 8) and female (n = 5) participants between the ages of 18 and 40
years old were recruited for this investigation. Inclusion criteria required a VO2peak of at least 35
ml•kg-1•min-1 to ensure the participants would be capable of completing the exercise within the
study. Participants with a history of acute mountain sickness or those with a known risk factor for
coronary artery disease were excluded from the study as determined by the physical activity
readiness questionnaire (PAR-Q). Females taking oral contraceptives or those without a regular
menstrual cycle within the previous eight months were excluded due to the potentially confounding
effects on hormonal status281. Participant characteristics are presented in Table 1.
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Table 1. Participant characteristics and exercise performance data
Characteristics

Combined

Participants (n)

13

Age (years)

24 ± 4

Height (cm)

177 ± 12

Body mass (kg)

72.2 ± 13.3

Percent fat (%)

15.8 ± 8.1

Fat Free Mass (kg)

60.8 ± 12.6

Fat Mass (kg)

11.4 ± 6.0

Exercise performance
VO2 max (L/min)

3.8 ± 0.8

VO2 max (ml.kg.-1min-1)

52.0 ± 6.4

Watt max (W)

290.5 ± 68.5

Data are presented as means ± SD
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Study Design
The investigation began with a baseline testing session to collect participant characteristic data,
including body composition and VO2peak. The subsequent laboratory visits included three exerciserecovery trials where recovery parameters from an identical exercise protocol were modified
according to simulated conditions of hypoxia and hypobaria. The experimental design is presented
in Figure 1.
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Normobaric-normoxia (NN) recovery trial

60 min 70% peak watts
Pre

Normobaria (675mmHg), Normoxia (18.8% FiO2)
Post

2Hr

4Hr

Hypobaric-hypoxia (HH) recovery trial

60 min 70% peak watts
Pre

Hypobaria (440mmHg), Hypoxia (12% FiO2)
Post

2Hr

4Hr

Normobaric-hypoxia (NH) recovery trial

60 min 70% peak watts
Pre

Normobaria (675mmHg), Hypoxia (12% FiO2)
Post

2Hr

4Hr

Figure 1. Experimental Design. Following characterization of height, weight, body composition
(hydrostatic weighing), participants completed 3 laboratory-based exercise recovery trials in a
randomized, counter-balanced fashion. All exercise trials involved an identical 60-minute bout of
cycle ergometry at 70% of peak watts. The experimental recovery conditions included three
simulated environmental conditions: Normobaric-normoxia (NN), base elevation (975 m)
atmospheric conditions, normobaria (675mmHg) and normoxia (18.8% FiO2, room air inspiratory
fraction); Hypobaric-hypoxia (HH), full high elevation simulation (4,420 m) atmospheric
conditions, hypobaria (440mmHg) and hypoxia (12% FiO2); or Normobaric-hypoxia (NH); partial
high elevation simulation (4,420 m) atmospheric conditions; normobaria (675mmHg) and hypoxia
(12% FiO2).
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Baseline Testing
Prior to baseline testing, participants were asked to fast for a duration of three-hours. Participant
characteristic data included the recording of height (Seca 213 Stadiometer, United Kingdom),
weight (Befour PS-660 ST Digital Scale, Saukville, WI), body composition, and VO2max
assessments. Body composition was quantified via hydrostatic weighing using an electronic load
cell-based system (Exertech, Dresbach, MN). Residual lung volume estimates were determined
and final body density values from underwater weighing were converted to percent body fat using
the Siri equation
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. Maximal oxygen uptake (VO2max) was quantified during a graded exercise

cycling protocol on an electronically braked Velotron cycle ergometer (RacerMate, Seattle, WA).
Starting at a workload of 95 watts, participants increased exercise intensity by 35 watts every 3minutes until volitional fatigue was achieved. The highest oxygen uptake value obtained from 15second intervals was used to determine VO2max. The maximum achieved workload (watts max) of
each participant was calculated from the time completed in the last stage, divided by the total stage
duration (3-min), multiplied by 35 watts, and added to the watts of the last completed stage
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.

Expired gases were quantified in 15-second intervals throughout the exercise test using a flowand gas-calibrated metabolic cart (Parvomedics TrueOne 2400, Sandy, UT).
Exercise-recovery trials
Each participant completed three exercise recovery trials in a randomized, counter-balanced
fashion. Exercise recovery trials were separated by 7 days in order to allow for biopsy recovery
and to eliminate between-trial acclimation. Subjects reported to the laboratory in the morning
following an eight-hour fast. Each exercise trial consisted of a 60-minute cycle ergometer
challenge at 70% watts max. Participants were provided water during the exercise trials ad libitum.
The amount of water consumed during the first exercise trial was replicated for the two subsequent
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trials. Upon completion of the exercise portion of each trial, a four-hour recovery period occurred
within a (32”x7’) cylindrical altitude chamber (Engineering Innovations, LLC, Littleton, CO).
Hypobaria was then combined with either normoxia or hypoxia (Tescor, Warminster, PA) to create
the recovery scenarios. A short break from the chamber was incorporated at the 2-hour midpoint
of each recovery trial due to biological need. The three experimental recovery conditions simulated
the following environmental altitudes with respect to barometric pressure as delineated below:
•

Normobaric-normoxia (NN); Base elevation (975 m) atmospheric conditions;
normobaria (675mmHg) and normoxia (18.8% FiO2, room air inspiratory fraction).

•

Hypobaric-hypoxia (HH); Full high elevation simulation (4,420 m) atmospheric
conditions; hypobaria (440mmHg) and hypoxia (12% FiO2).

•

Normobaric-hypoxia (NH); Partial high elevation simulation (4,420 m) atmospheric
conditions; normobaria (675mmHg) and hypoxia (12% FiO2).

Exercise-recovery oxygen saturation and heart rate
Tissue oxygen saturation and heart rate was recorded before and during exercise as well as at 60minute intervals throughout the recovery period using finger pulse oximetry (Nonin WristOx2
3150, Plymouth, MN).
Phlebotomy and blood plasma collection
For each of the exercise-recovery trials, whole blood samples were collected from the antecubital
vein with sodium heparinized vacutainers. Venipuncture was performed pre- (Pre), post- (Post),
two (2-HR), and four (4-HR), hours post exercise. Blood samples were centrifuged at 1000 x g for
15-minutes at 4°C, and the plasma fraction was aliquoted and stored immediately at -80°C until
subsequent biochemical assay for oxidative damage and antioxidant biomarkers.
Exercise-recovery trial muscle biopsies
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Muscle biopsies were obtained before and after each exercise recovery trial from the vastus
lateralis. Muscle samples were extracted with the aid of suction using a 5 mm Bergstrom
percutaneous biopsy needle. Left and right legs used for biopsy were chosen randomly and
counter-balanced between trials. Incision sites were cleaned and three to four mL of 1% lidocaine
was injected subcutaneously and around the muscle fascia prior to incision. Next, a small incision
was created through the skin and muscle fascia, followed immediately by the biopsy process. Post
recovery biopsies were extracted from a separate incision ~ 2 cm proximal to pre-exercise biopsies.
Newly obtained muscle tissue samples were quickly cleaned of surface blood, connective tissue,
and fat prior to submersion in All-protect (Qiagen, Hilden, North Rhine-Westphalia, Germany).
Samples were then stored at -30°C until assay.
Biochemical oxidative stress panel
Blood oxidative stress was quantified using a comprehensive panel that included markers of
oxidative damage and antioxidant content. Oxidative damage markers included two lipid-based
markers, lipid hydroperoxides (LOOH) and 8-Isoprostanes (8-ISO), and two protein-based
markers, protein carbonyls (PC) and nitrotyrosines (3-NT). Measures of plasma antioxidant
capacity included Trolox equivalent antioxidant capacity (TEAC) and Ferric reducing antioxidant
potential (FRAP). Individual blood plasma aliquots were subjected to a single freeze-thaw cycle
to preserve sample viability for the various redox-sensitive markers. Plasma aliquots were kept on
ice in a dark environment during assay to prevent confounding final results with environmental
redox alterations.
Plasma antioxidant capacity
Trolox equivalent antioxidant capacity was performed using a quantifiable colorimetric reaction
whereby plasma antioxidants scavenge exogenous introduction of 2, 2’ azinobis 3-ethyl-
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benzothiazoline-6-sulfonic acid (ABTS) radical anions. The formulation of the assay work
solution began with 50 mM Glycine buffer and a 2.5 mM Trolox solution. Then, glycine
peroxidase was added to 50 mM glycine buffer, followed by the addition of ABTS solution and
22 mM H2O2, in the final work solution. Final calculated TEAC values were derived from unknown
plasma samples using the water-soluble vitamin E analogue Trolox as a standard reference284. The
FRAP assay was performed using a colorimetric reaction, which quantifies an exogenous ferricto-ferrous tripyridyltriazine (TPTZ) reduction by antioxidants present within plasma. Within the
FRAP assay, reduction of TPTZ is proportional to blood plasma antioxidant capacity and was
quantified by absorbance spectroscopy at 593 nm according to established methodology285.
Plasma oxidative damage
Plasma LOOH were quantified using the ferrous oxidation-xylenol orange assay. Plasma samples
were incubated in the presence or absence of a reducing agent and incubated with a colorimetric
work solution containing ferrous ammonium sulfate, butylated hydroxytolene, and xylenol orange.
During the assay reaction, oxidized ferrous ions oxidize the ferrous sensitive dye contained in
xylenol orange to form a quantifiable complex that was measured via absorbance spectroscopy at
595 nm. Final LOOH concentrations in unknown blood plasma samples were derived using a
cumene hydroperoxide standard reaction286. Blood plasma 8-ISO concentrations were quantified
by a commercially available specific immunoassay enzyme (EIA) (Cayman Chemical, Ann Arbor,
MI) and assay procedures were performed according to manufacturer instructions287.
Prior to quantification of oxidative damage to plasma proteins, sample protein concentrations were
determined using the spectrophotometric Bradford method288. Samples were then normalized for
either PC or 3-NT assays. PC determination in blood plasma samples was performed by a
commercially available ELISA kit according to manufacturer instructions (Biocell Corporation
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Ltd, Papatoetoe, NZ)289. Samples were diluted based on anticipated ranges of 4-35 mg protein/ml.
Final concentrations were calculated based on spectrophotometric absorbance readings at 450 nm.
3-NT content in blood plasma samples was determined via commercial ELISA and assayed
according to manufacturer instructions (Cell Biolabs INC, San Diego, CA). Similar to PC, final 3NT concentration were determined from spectrophotometric readings at 450 nm290.
Muscle Sample Preparation and qRT-PCR
Skeletal muscle (11.5 ± 1.7 mg) samples were processed in 500 µL of Trizol (Invitrogen, Carlsbad,
CA) using an electric blender homogenizer (Bullet Blender, Next Advance, Inc, Averill Park, NY)
in 1.5 mL Red RINO tubes prefilled with RNase free ceramic beads (Next Advance, Inc, Averill
Park, NY). Homogenate was centrifuged at 12,000 g for 15-min and the aqueous phase isolated
and incubated overnight at -20°C. Centrifugation was used to create a pellet, followed by
resuspension in ethanol, and a 5-minute centrifugation at 7,500 g. Ethanol was removed, the pellet
dried, and re-dissolved in 30 µL of RNase-free water. RNA concentrations were quantified using
a nano-spectrophotometer (nano-drop ND-2000, Thermo Scientific, Wilmington, DE). Average
RNA yields were 165.9 ± 12.1 ng·µl-1 and average absorbance ratio at 260:280 exceeded 1.90 as
a means of determining RNA purity. RNA sample integrity (RNA integrity = 8.0 ± 0.1) was
assessed using a 2100 Agilent Bioanalyzer and Agilent RNA 6000 Kit (Agilent Technologies,
Santa Clara, CA). First-strand cDNA synthesis was achieved using the Superscript IV-first strand
synthesis system for RT-PCR kit (Invitrogen, Carlsbad, CA) and the resulting cDNA diluted with
RNase-free water to achieve a final cDNA concentration of 0.5 µg/µL for resultant PCR reactions.
qRT-PCR reactions contained 0.5µL of probe/primer mix (PrimeTime qPCR assay Integrated
DNA Technologies, Coralville, IA), 5µL qPCR Master Mix (Integrated DNA Technologies,
Coralville, IA), and 4.5µL sample cDNA. PCR was performed in triplicate on a Startagene
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mx3005p PCR system (Agilent Technologies) using a 2-step protocol (1-5 second cycle at 95°C,
50-20second cycles at 60°C). Redox-sensitive transcripts included endothelial PAS domain
protein-1 (EPAS-1), hemeoxygenase-1 (HMOX1), superoxide dismutase-2 (SOD2), and nuclear
factor erythroid-derived 2-like 2 (NFE2L2). mRNA quantification was completed using the 2-∆∆CT
method (Livak&Schmittgen. 2001). The geometric mean of five housekeeping genes: beta-actin
(ACTB), beta-2-microglobulin (B2M), cyclophilin (CYC), ribosomal protein S18 (RPS-18), and
glyceraldehyde-3 phosphate dehydrogenase (GAPDH) were used as a reference for each
participant. This reference gene combination was determined by established NormFinder software
(Andersen, et al. 2004). qRT-PCR probe and primer sequences are presented in Table 2.
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Table 2. Probe and primer sequences for reference genes and genes of interest
Gene symbol

Gene accession #

EPAS-1

NM_001430

Probe

Primer 1

Primer 2

/56-FAM/AGA ACT

CTT TGC GAG CAT

AGC CTA TGA ATT

TGT GCA CCA

CCG GTA

CTA CCA TGC G

/56-FAM/TTC AAG

TCC TTG TTG

AGA ATG CTG

CTG /ZEN/GTG ATG

CGC TCA ATC TC

AGT TCA TGA

A/3IABkFQ
HMOX1

NM_002133

GCC TCC

GGA A

C/3IABkFQ/
SOD2

NM_000636

/56-FAM/TGG CTT

CGT CAG CTT

GAC AAA CCT

CCA /ZEN/GCA ACT

CTC CTT AAA

CAG CCC TAA CG

CCC CTT

CTT G

T/3IABkFQ/

NFE2L2

NM_006164

/56-FAM/CTA CTC

GCA GTC ATC

ACA TCC AGT CAG

CCA /ZEN/GGT TGC

AAA GTA CAA

AAA CCA GTG

CCA CAT

AGC A

TCC/3IABkFQ/

Redox sensitive gene transcripts were quantified by qRT-PCR from vastus lateralis muscle biopsy samples;
Endothelial PAS domain protein-1 (EPAS-1), Hemeoxygenase-1 (HMOX1), Superoxide Dismutase-2 (SOD2), and
Nuclear Factor Erythroid-derived 2-like 2 (NFE2L2).
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Statistical Analysis
Blood plasma variables and redox-sensitive gene transcripts responses were examined between
NN, HH, and NH trials using repeated-measures ANOVAs (trial x time) with a Bonferroni
correction. Where violations of sphericity occurred, the Greenhouse-Geisser correction was used
to adjust the degrees of freedom. In the event that an interaction effect occurred, a Tukey’s Post
Hoc test was used to identify differences between time points and trials. All statistical procedures
were performed using the Statistical Package for Social Sciences software (SPSS) Version 24.0
(Chicago, IL). All values are presented as means ± standard deviation (SD). Significance was set
at p ≤ 0.05 a priori.
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RESULTS
Exercise Trials
No main effect of trial was observed in HR (p = 0.387); however, a significant time effect occurred
(p < 0.001). HR was significantly elevated during EX (p < 0.001) and remained elevated at POST
(p < 0.001).
Oxygen saturation during recovery
Exercise-recovery oxygen saturation data are presented in Figure 2. A significant effect for trial
(p < 0.001), time (p < 0.001), and interaction (p = 0.037) occurred. Due to the observed interaction
effect, a Tukey’s Post Hoc test was utilized to further analyze the interaction effect. Oxygen
saturation was significantly lower in the NH trial when compared to the NN trial at 1-HR, 2-HR,
3-HR, and 4-HR (p < 0.005). Additionally, oxygen saturation was significantly lower in the HH
trial when compared to the NN trial at 1-HR, 2-HR, 3-HR, and 4-HR (p < 0.005).
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NH

HH

NN

120

Oxygen Saturation (%)

90

60

30

0
Baseline

Exercise

Post-Exercise

1-HR

2-HR

3-HR

4-HR

Figure 2. Data are presented as means ± SD. * significantly different from PRE. ⊥ significantly
different from NN trial.
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Plasma antioxidant status
Mean responses for plasma antioxidant status assessed through the measurement of TEAC and
FRAP are presented in Figure 3A and 3B. A significant time effect (p = 0.012) was present for
TEAC values, with an increase at POST (p = 0.011) and a return to baseline at 2-HR (p = 0.288)
and 4-HR (p = 0.149). Similar to TEAC, FRAP demonstrated a significant time effect (p = 0.001),
with an increase at POST (p = 0.006), but statistical analyses indicated a returned to baseline values
by 2-HR and 4-HR (p > 0.99). No differences between trials were observed in TEAC (p = 0.093)
or FRAP (p = 0.050), which indicated that increases in antioxidant markers were related to the
bout of exercise.
Biomarkers for plasma oxidative damage
Biomarkers for oxidative damage as quantified by LOOH and 8-ISO are presented in Figure 3C
and 3D. Analysis of LOOH findings indicated a main effect of trial (p = 0.005) and time (p =
0.019); however, no trial x time interaction was observed (p = 0.064). At 2-HR, LOOH was
significantly higher than the POST time point (p = 0.011). It is plausible that the observed main
effect was not caused by the environmental conditions considering the values were also elevated
at PRE, before exercise and any environmental condition was introduced. 8-ISO was unaffected
by trial (p = 0.263), but a time effect was observed (p = 0.001). 8-ISO was significantly increased
at 2-HR (p = 0.044), indicating an exercise-induced elevation.
Protein modification biomarkers PC and 3-NT are presented in Figure 3E and 3F. Statistical
analysis indicated there was no effect of trial on PC (p = 0.368); however, there was a main effect
of time (p < 0.001). Exercise resulted in a significant decrease of PC at 2-HR (p = 0.002) when
compared to pre-exercise values. For 3-NT, there was no main effect of trial (p = 0.222), but a
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significant time effect occurred (p = 0.006). A mean decrease of 3-NT occurred at the 2-HR time
point (p = 0.001).

65

Figure 3. (A) Trolox equivalent antioxidant capacity values are expressed as Trolox equivalent
antioxidant capacity equivalents (µmol/L) for normobaria normoxia (black bars), hypobaria
hypoxia (white bars), and normobaria hypoxia (shaded bars). (B) Ferric-reducing ability of
plasma values are expressed as ascorbate in equivalents (µmol/L) for normobaria normoxia (solid
black bars), hypobaria hypoxia (solid white bars), and normobaria hypoxia (shaded bars). (C)
Plasma lipid hydroperoxides are expressed as lipid hydroperoxide equivalents (µM) for
normobaria normoxia (black bars), hypobaria hypoxia (white bars), and normobaria hypoxia
(shaded bars). (D) Plasma 8-Isoprostanes values are expressed in standard comparison to 8isoprostanes protein content (pg/ml), for normobaria normoxia (black bars), hypobaria hypoxia
(white bars), and normobaria hypoxia (shaded bars). (E) Plasma Protein Carbonyl values are
expressed in standard comparison to Protein Carbonyl equivalents (µmol/mg prot) for normobaria
normoxia (black bars), hypobaria hypoxia (white bars), and normobaria normoxia (shaded bars).
(F) Plasma Nitrotyrosine values are expressed in standard comparison to Nitrotyrosine protein
content (µg/ml) for normobaria normoxia (black bars), hypobaria hypoxia (white bars), and
normobaria hypoxia (shaded bars). Means are expressed ± SD. *significantly different from PRE;
#
significantly different from POST; ⟘ significantly different from normobaria normoxia recovery.
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Gene Expression
Gene expression of NFE2L2, HMOX1, SOD2, and EPAS measured at PRE and 4-HR are
presented in in Figure 4. There was no main effect of trial in NFE2L2 (p = 0.509); however, a
main effect of time was observed (p = 0.003). A significant increase in NFE2L2 occurred at 4-HR
(p = 0.003), indicating an exercise-induced increase. Similar to NFE2L2, no effect of trial occurred
in HMOX1 (p = 0.519), but a time effect was observed (p < 0.001). HMOX1 was significantly
elevated at 4-HR (p < 0.001) following the bout of exercise. No main effect of trial was observed
in SOD2 (p = 0.691), but a time effect occurred (p = 0.046) with a significant increase above preexercise values at 4-HR (p = 0.046). Finally, there was no main effect of trial in EPAS (p = 0.282);
however, a time effect occurred (p = 0.038) with a significant elevation at 4-HR (p = 0.038).
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A

B
16

*

6

4

2

HMOX1 (arbitrary units)

EPAS (arbitrary units)

8

0

*
12

8

4

0
PRE

4-HR

PRE

C

D

2.5

2.5

*

2.0

NFE2L2 (arbitrary units)

SOD2 (arbitrary units)

4-HR

1.5
1.0
0.5
0.0

*

2.0
1.5
1.0
0.5
0.0

PRE

4-HR

PRE

4-HR

Figure 4. Data are presented as means ± SD. (A) EPAS (B) HMOX1 (C) SOD2 (D) NFE2L2;
black bars represent normobaria normoxia, white bars represent hypobaria hypoxia, and shaded
bars represent normobaria hypoxia; * significantly different from PRE.
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DISCUSSION
The purpose of this investigation was to examine the independent and collective effects of
hypobaria and hypoxia on post-exercise oxidative stress responses. These outcomes were
quantified utilizing a panel of oxidative damage markers, antioxidant capacity/potential, and
redox-sensitive gene transcripts collected in a controlled laboratory setting. In order to assess the
effects of the environmental variables on post-exercise oxidative stress, normobaric hypoxia and
hypobaric hypoxia were manipulated during exercise recovery. The results of the current
investigation demonstrated no effect of hypobaria or hypoxia on markers of oxidative stress
(LOOH, 8-ISO, PC, 3-NT) or antioxidant capacity/potential (TEAC, FRAP) during post-exercise
recovery. Of note, exercise elicited an increase two-hours after exercise in LOOH and 8-ISO, but
these responses were not impacted by alterations in the hypoxic or hypobaric recovery conditions.
In further support, redox sensitive transcripts (EPAS, HMOX1, SOD2, NFE2L2) were elevated in
the post-exercise muscle biopsy samples, but variations in the hypoxic or hypobaric recovery
conditions did not have an intervening influence. These findings are contrary to our working
hypothesis that hypoxia and hypobaria would blunt the post-exercise oxidative stress response,
and they are discussed subsequently.
Antioxidant Status
Antioxidant status was assessed through the quantification of antioxidant capacity (TEAC) and
antioxidant potential (FRAP). Within the current investigation, both TEAC and FRAP were
unaffected by recovery under both hypobaric and hypoxic conditions. Our findings are in conflict
with prior work, in which Ballmann et al. demonstrated that recovery in a hypoxic environment
mitigated the exercise-dependent increase of FRAP and TEAC that typically occurs in a normoxic
environment15. The exercise bout selected within the aforementioned study was longer in duration
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(90-minutes) and consisted of intervals that peaked at a much higher exercise intensity (80%
VO2max). In further support, Peters et al. examined the effects of hypoxia on recovery of blood
oxidative stress following one-hour of cycling at 70% VO2max17. An exercise-induced elevation of
TEAC and FRAP was observed, but there were no differences between recovery in a hypoxic
environment (1667m, 3333m, or 5000m) when compared to normoxia17. Although an exerciseinduced increase in TEAC and FRAP was present within the current study, the magnitude of the
oxidative stress response was modest and may not have been sufficient to observe changes among
the environmental conditions. Importantly, previous research has demonstrated a post-exercise
drop in FRAP, with no observed changes in TEAC, following one-hour of moderate-intensity
cycling exercise (60% VO2peak) under normoxic and hypoxic conditions; thus, biomarkers of
antioxidant status are not always elevated in response to a bout of exercise14.
Markers of Protein Damage
When examining biomarkers of protein damage, the current investigation demonstrated a mean
decrease in both PC and 3-NT following exercise, with no differences occurring between
normoxic, hypoxic, or hypobaric recovery trials. Previous research examined cycling exercise at
70% VO2peak, which elicited an elevation in PC concentrations that returned to baseline levels
within one-hour after the cessation of exercise102. When considering the combined effects of
exercise and altitude, Peters et al., who conducted a well-controlled, laboratory-based study,
observed an increase in PC five-hours after a 60-minute bout of cycle ergometry at 70% VO2max;
however, PCs were unaffected by the hypoxic recovery when compared to normoxic recovery17.
Within the current study, the sampling time points did not extend to five-hours post-exercise; thus,
it is possible that the elevation in PCs was not captured. Although, an investigation examining the
effects of hypoxic conditions following a cycling bout at 60% of VO2peak demonstrated a drop PC
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similar to the findings of the current study, following exercise and unchanged by the hypoxic
recovery conditions14. It is possible that observed decrease was due to the spontaneous oxidation
of proteins, and subsequent clearance291.These data are in support of the working theory that the
exercise stimulus must be sufficient to produce an elevation in markers of protein damage; thus, it
is not possible to draw clear conclusions on the effects of the environmental recovery conditions.
For instance, previous work has demonstrated that hypoxic recovery environments blunt the
necessary oxidative stress response to exercise15. However, if a sufficient exercise-dependent
increase is not observed, then it is not possible to determine if the hypoxic or hypobaric conditions
resulted in mitigation of the exercise-induced oxidative stress.
Markers of Lipid Damage
The current investigation demonstrated no effect of hypoxic or hypobaric recovery on LOOH, a
marker of lipid damage. In response to exercise, LOOH were elevated at 2-HR, when compared
to the immediate post-exercise values. Previous research on the LOOH response to hypoxic
exercise has been inconclusive14, 15, 17. An investigation conducted by Peters et al. demonstrated a
significant exercise-dependent elevation in LOOH as well as differences in the oxidative stress
response when recovery occurred under hypoxic conditions17. Following a one-hour bout of
cycling exercise at 70% VO2max, the magnitude of elevation in LOOH during the recovery period
was greatest in the normoxic environment, with an elevation of lesser magnitude occurring at
3333m. These data suggest that LOOH elevation may be blunted under hypoxic conditions17. In
contrast, previous work by Ballmann et al. exhibited an exercise-induced decrease in LOOH
immediately after 90-minutes of interval exercise, with no differences in the recovery period when
comparing normoxic and hypoxic conditions15. Additionally, LOOH become elevated following
higher intensity exercise in both normoxic and hypoxic recovery environments14. Evidence
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supports the sensitivity of lipid peroxidation to both intensity and volume of exercise13. Therefore,
it is likely the divergent responses can be explained by the selected exercise stimuli of the previous
studies.
Redox-Sensitive Gene Transcripts
In order to understand the effects of hypobaric and/or hypoxic conditions on the recovery of blood
oxidative stress following exercise, four redox-sensitive gene transcripts were examined before
and four-hours following exercise. Redox-sensitive gene transcripts selected for the current
investigation include EPAS, HMOX1, SOD2, and NFE2L2. These data collectively demonstrated
an exercise-induced increase in all four redox-sensitive gene transcripts at the 4-HR time point,
indicating the exercise-stimulus was sufficient to elicit a modest blood oxidative stress response.
Previous literature indicates that HMOX1, SOD2, NFE2L2 increase with exercise292-296.
Importantly, none of the redox sensitive gene transcripts were affected by the environmental
recovery conditions. Previous work had examined the effect of both normobaria hypoxia and
hypobaria hypoxia on gene transcripts of mitochondrial biogenesis, which is known to be
upregulated with exercise297. The findings demonstrated no differences in mitochondrial-related
gene expression with normobaria hypoxia or hypobaria hypoxia297, 298. Similar to the findings of
the current study, Peters et al. found no differences among NFE2L2 or SOD2 during the exercise
recovery period under three different hypoxic conditions (1667m, 3333m, 5000m)17. Of note, it
has been suggested that exercise in hypobaric and hypoxic may not result in hypoxia at the level
of the tissues299. However, previous research has determined the exercise-induced response of
NFE2L2 and SOD2 can be blunted when recovery occurs under hypoxic conditions15. When
examining HMOX1, our findings are in agreement with those who have shown no effect of
hypoxia during post-exercise recovery15, 17.
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Conclusion
Although the current study was carefully designed and implemented, it is not without its
limitations. For instance, the four-hour recovery period in which the participants were exposed to
the experimental conditions was interrupted by a brief break after two hours. This aspect of the
study design was included in order to consistently meet the anticipated need for a biological break
from the altitude chamber. Additionally, the findings of the study would have benefitted from an
additional trial to examine hypobaric normoxic condition, to further isolate the effects of hypobaria
on post-exercise recovery. Based upon prior observations that hypoxic recovery blunted the postexercise oxidative stress response, the current study was undertaken to determine whether this
outcome could be attributed to hypobaria, hypoxia, or the combination of both. Under these
constraints, where post-exercise hypoxia and hypobaria were examined within a controlled
laboratory setting, it was determined that there were no observed changes in exercise-induced
oxidative stress responses under the conditions of normobaric normoxia, normobaric hypoxia, and
hypobaric hypoxia. Thus, these environmental factors were not as impactful as hypothesized.
However, we confirmed that the exercise challenge imposed a modest oxidative stress response,
as indicated by elevations in markers of antioxidant capacity/potential, lipid damage, and redoxsensitive gene transcripts. Based on the comparison of these findings with previous work14-17, 298,
a more intensive and/or longer duration exercise bout could have elicited a more robust oxidative
stress response. It is possible that achieving a certain threshold of oxidative stress is necessary to
identify an environmentally-dependent blunting of the oxidative stress response to exercise.
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Chapter V: Fifteen Exercise Training Sessions in a Hot Environment Fail to Elicit Changes
in the Blood Oxidative Stress Response
ABSTRACT
Environmental temperature can impact exercise-induced blood oxidative stress; however, the
effects of heat acclimation on this response have not been fully elucidated. The purpose of the
study was to investigate the effects of hot (33°C) and room temperature (20°C) environments on
post-exercise blood oxidative stress responses following 15 temperature acclimation sessions.
Untrained participants (n = 38, 26 ± 7 years, VO2peak = 38.0 ± 7.2 years) completed 15 temperature
acclimation sessions of a cycling bout at an intensity perceived as “hard” in either a hot (33°C) or
room temperature (20°C) environment. Pre and post acclimation exercise tolerance trials were
conducted, which involved cycling at 50% Wpeak for one hour. Blood sampling occurred before
(Pre), immediately after (Post), two hours (2-HR), and four hours (4-HR) after the exercise
tolerance trials. Blood samples were analyzed for oxidative stress markers including lipid
hydroperoxides (LOOH), 8-isoprostanes (8-ISO), protein carbonyls (PC), 3-nitrotyrosine (3-NT),
ferric-reducing ability of plasma (FRAP), and Trolox-equivalent antioxidant capacity (TEAC).
Exercise-dependent increases were observed in LOOH, TEAC, and FRAP (p < 0.001). While
exercise-induced elevations in markers of blood oxidative stress, there were no differences
observed between environmental temperatures before or after the acclimation training period.
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INTRODUCTION
Oxidative stress occurs with the excessive production of highly reactive molecules, termed reactive
oxygen species (ROS), which provoke damage to cellular components7,

20, 300, 301.

Chronic

oxidative stress is associated with the pathophysiology of various diseases (e.g., cancer); however,
acute perturbations are necessary to initiate adaptive responses12, 20-23. Exercise results in acute
redox perturbations that elicit exercise-induced adaptations12, 13, 23. Previous investigations reveal
that ambient temperature impact the oxidative stress response independent of exercise and in
response to acute hyperthermic exercise23-25, 302. For instance, treadmill running at low-intensity
exercise (50% VO2max) within hyperthermic conditions (35°C, 70% relative humidity) resulted in
a significant elevation in plasma F2-isprostanes, indicating cellular lipid damage24. Additionally,
there is evidence to support that six-minutes of one-legged knee extensor exercise leads to an
elevation in antioxidant capacity302.
Although blood oxidative stress responses to exercise in hyperthermic conditions have been
investigated, the effects of hyperthermic exercise training on the blood oxidative stress response
remains understudied. To date, one investigation has examined the effects of hyperthermic
exercise training with four-weeks of high-intensity interval training (HIIT) on the blood oxidative
stress response to acute exercise in trained male subjects. The investigation determined that
biomarkers of lipid peroxidation were elevated following the training period; however, markers of
protein damage (protein carbonyls) were blunted by hyperthermic exercise training26. Additional
research is required to understand the impact of hyperthermic exercise training on the blood
oxidative stress response to various modalities and/or intensities of exercise. Therefore, the
primary purpose of the current investigation was to examine the effects of three-weeks of heat
acclimation training on the blood oxidative stress response to an acute bout of moderate-intensity
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aerobic exercise. A strategic panel of blood oxidative stress biomarkers was selected to quantity
lipid damage (lipid hydroperoxides, LOOH; 8-isoprostane, 8-ISO), protein damage (protein
carbonyls, PC; 3-nitrotyrosine, 3-NT), and antioxidant status (Trolox equivalent antioxidant
capacity, TEAC; Ferric reducing ability of plasma, FRAP). We hypothesized heat acclimation
training would result in a blunting of the acute oxidative stress response to exercise under
hyperthermic conditions following the three-week acclimation period.
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METHODS
Participants
Participant characteristics are presented in Table 1. Untrained male (n = 25) and female (n = 13)
participants between the ages of 19 and 40 years old were recruited for the investigation.
Participants were considered untrained if they had not participated in a structured cardiovascular
exercise program within the previous three months. Inclusion criteria required successful screening
using a Physical Activity Readiness Questionnaire. Females without a regular menstrual cycle or
those taking oral contraceptives within the previous eight months were excluded due to the
potentially confounding effects of hormonal status. The investigation was approved by the
Institutional Review Board (IRB) and the United States Army Medical Research and Development
Command (USAMRMC) Human Research Protections Office (HRPO). Participants granted
written consent prior to study initiation.
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Table 1. Participant Characteristics
Characteristic
Age (yrs)

PRE

POST

26 ± 7

Height (cm)

179.6 ± 8.4

Weight (kg)

85.2 ± 21.1

85.6 ± 21.2

Wmax (W)

218 ± 46

251 ± 42

VO2peak (mL∙kg-1∙min-1)

38.0 ± 7.2

41.5 ± 7.9

*N = 38; Values presented in mean ± SD.
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Study Design
The investigation began with a baseline testing session to determine participant body composition
and aerobic capacity (VO2peak). Participants were randomly assigned to a group in either a hot
(33°C) or room temperature (20°C) environment. On a separate visit, participants completed an
exercise tolerance trial of cycling at 50% Wpeak for a duration of 60 minutes in the assigned
environmental temperature. Participants continued the study with three weeks of acclimation
training, which required cycling for 60 minutes at an intensity perceived as “hard,” over the course
of 15 exercise sessions. After the completion of the acclimation training sessions, the exercise
tolerance trial was repeated. Blood samples were collected prior to exercise (Pre), immediately
post exercise (Post), two hours (2-HR), and four hours (4-HR) post exercise for the quantification
of blood oxidative stress. The experimental design is presented in Figure 1.
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Pre- and Post- Acclimation Training Exercise Tolerance Trials

1-hour 50% Wpeak
Hot
(32ºC, 40% RH)
Pre

Recovery
15-18°C, 40% RH
Post

2Hr

1-hour 50% Wpeak
Neutral
(18ºC, 40% RH)
Pre

4Hr

Recovery
15-18°C, 40% RH
Post

2Hr

4Hr

Figure 1. Experimental Design. Participants completed a pre- and post- acclimation trial separated
by 15 exercise training sessions. Pre and post acclimation trials involved an identical 60 minute
bout of cycle ergometry at 50% of Wpeak. The experimental conditions included the following
environmental conditions: Hot (33ºC, 40% Relative Humidity) and Room Temperature (20ºC,
40% Relative Humidity).
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Pre- and Post- Training Fitness Assessment
Fitness assessments were completed for all participants before and after the three-week training
period. Fitness assessments consisted of body composition analysis and an aerobic capacity test
(VO2peak). Body composition was quantified via hydrostatic weighing using an electronic load cellbased system (Exertech, Dresbach, MN). Residual lung volume estimates were determined and
final body density values were converted to percent body fat using the Siri equation282. Peak
oxygen uptake (VO2peak) was quantified during a graded exercise cycling protocol on an
electronically braked cycle ergometer (Velotron, RacerMate, Seattle, WA). Starting at a workload
of 95 watts, participants increased exercise intensity by 35 watts every three minutes until
volitional fatigue was achieved. The highest oxygen uptake value obtained from 15 second
intervals was used to determine VO2peak. Expired gases were quantified throughout the exercise
test using a flow- and gas-calibrated metabolic cart (Parvomedics TrueOne 2400, Sandy, UT).
Exercise Tolerance Trials
Participants performed the exercise tolerance trials on the first and last day of training. The exercise
tolerance trials were conducted in a hot environment (33°C, 40% relative humidity) or a room
temperature environment (20°C, 40% relative humidity), followed by a four-hour recovery period
at 15-18°C. Prior to the trials, participants were asked to abstain from exercise for 48 hours, alcohol
for 24 hours, and fast for a period of eight hours prior to testing. Before the first exercise tolerance
trial, a 24-hour dietary recall was completed and replicated for the subsequent trial. Upon arrival,
participants were fitted with skin temperature sensors on the chest and back (SST-1 Skin Probe,
Physitemp Instruments, Clifton NJ) and a rectal thermometer for the quantification of skin and
core temperature (RET-1 Rectal Probe, Physitemp Instruments, Clifton, NJ). Heart rate monitoring
(Polar V800, Polar Electronic, Lake Success, NY) was performed continuously throughout each

81

trial. Participants completed 60 minutes of cycling at 50% Wpeak on a cycle ergometer (Velotron)
within their assigned environmental condition. Venous blood samples were collected at Pre, Post,
2-HR, and 4-HR after the exercise tolerance trials for the quantification of blood oxidative stress.
Daily Exercise Training Sessions
Participants arrived at the laboratory every weekday (Monday-Friday) for three weeks to complete
the exercise training sessions. The training sessions consisted of 60 minutes of cycle ergometery
at an intensity rated at 15 (hard) on the Borg Rating of Perceived Exertion (RPE) scale303, 304.
Subjects were instructed to adjust exercise intensity to maintain an RPE of 15 throughout the
training period. All training sessions were conducted in the assigned environmental temperature.
Heart rate and core body temperature were continuously monitored during each training session.
Phlebotomy and blood plasma collection
During the exercise tolerance trials, whole blood samples were collected from the antecubital vein
with sodium heparinized vacutainers. Venipuncture occurred Pre, Post, 2-HR, and 4-HR after the
conclusion of the exercise tolerance trial. Blood samples were centrifuged at 1000 x g for 15minutes at 4°C. Plasma aliquots were stored immediately at -80°C until subsequent biochemical
assay for oxidative damage and antioxidant biomarkers.
Biochemical oxidative stress panel
A comprehensive panel of blood oxidative stress was used to quantify oxidative damage and
antioxidant content. Lipid-based oxidative damage was measured through LOOH and 8-ISO, and
protein-based oxidative damage was measured via PC and 3-NT. Plasma antioxidant capacity was
measured by TEAC and FRAP. Blood plasma aliquots were subjected to a single freeze-thaw cycle
and were kept on ice in a dark environment during assay to prevent confounding results with
environmental redox alterations.
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Plasma antioxidant capacity
A quantifiable colorimetric reaction was used for the quantification of TEAC. Plasma antioxidants
scavenge exogenous introduction of 2, 2’ azinobis 3-ethyl-benzothiazoline-6-sulfonic acid
(ABTS) radical anions. The formulation of the assay work solution began with 50 mM Glycine
buffer and a 2.5 mM Trolox solution. Glycine-peroxidase concentrate was added to the 50 mM
glycine buffer. The addition of ABTS solution and 22 mM H2O2 resulted in the final work solution.
Final calculated TEAC values were derived from unknown samples using the water-soluble
vitamin E analogue Trolox as a standard reference284. A colorimetric reaction was used for the
FRAP assay, which quantifies an exogenous ferric-to-ferrous tripyridyltriazine (TPTZ) reduction
by antioxidants present within plasma. Within the FRAP assay, reduction of TPTZ is proportional
to blood plasma antioxidant capacity and was measured by absorbance spectroscopy at 593 nm285.
Plasma oxidative damage
Plasma LOOH were quantified using the ferrous oxidation-xylenol orange assay. Plasma samples
were incubated in the presence or absence of a reducing agent and incubated with a colorimetric
work solution containing ferrous ammonium sulfate, butylated hydroxytoluene, and xylenol
orange. During the assay reaction, ferrous ions oxidize within the xylenol orange solution to form
a quantifiable complex that was measured via absorbance spectroscopy at 595 nm. Final LOOH
concentrations in unknown samples were derived using a cumene hydroperoxide standard
reaction286. Blood plasma 8-ISO concentrations were quantified by a commercially available
specific immunoassay enzyme (EIA) (Cayman Chemical, Ann Arbor, MI) and assay procedures
were performed according to manufacturer instructions287.
Prior to quantification of protein-based oxidative damage markers, sample protein concentrations
were determined using the spectrophotometric Bradford method and then normalized for either PC
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or 3-NT assays based on the results of the Bradford288. PC determination in blood plasma samples
was performed by a commercially available ELISA kit according to manufacturer instructions
(Biocell Corporation Ltd, Papatoetoe, NZ)289. Samples were diluted based on anticipated ranges
of 4-35 mg protein/ml. 3-NT content in blood plasma samples was determined via commercial
ELISA and assayed according to manufacturer instructions (Cell Biolabs INC, San Diego, CA).
Final concentrations for both PC and 3-NT assays were calculated based on spectrophotometric
absorbance readings at 450 nm.
Statistical Analysis
Blood oxidative stress responses were examined between the hot (33°C, 40% relative humidity)
and room temperature (20°C, 40% relative humidity) groups using a 2 x 2 x 4 (temperature x trial
x time) repeated-measures analysis of variance (ANOVA). Peak responses were determined by
comparing the baseline values (Pre) with the highest elevated value of each blood oxidative stress
marker (Peak). A 2 x 2 x 2 repeated-measures ANOVA (temperature x trial x time) was used to
assess differences in peak responses between the temperature trials. Statistical procedures were
performed using the Statistical Package for Social Sciences software (SPSS) Version 25.0
(Chicago, IL). All values are presented as means ± standard error mean (SEM). Significance was
set at p ≤ 0.05 a priori.
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RESULTS
Lipid Damage
Biomarkers for oxidative damage as quantified by LOOH and 8-ISO are presented in Figure 2A
and 2B. For LOOH, no differences were observed between the hot and room temperature
environments (p = 0.204) Exercise resulted in an elevation of LOOH at 2-HR (p = 0.001) and 4HR (p < 0.001). Pre and post acclimation trial-dependent differences (p < 0.001) occurred, and a
significant trial x time interaction effect was present (p = 0.018). Pairwise comparisons revealed
that all LOOH values were higher in the second trial in both environmental temperatures (p<0.05),
indicating that exercise training resulted in elevated blood plasma levels of LOOH. Peak responses
of LOOH were not different between environmental temperatures (p=0.128), but a significant
elevation occurred with exercise (p<0.001). Additionally, when examining peak responses an
effect of pre and post acclimation trial (p<0.001) occurred, as well as a trial x time interaction
(p=0.026). Further examination of the interaction effect for peak responses of LOOH also revealed
that all post-acclimation training values were significantly higher than pre-acclimation training
values (p<0.05). 8-ISO was unaffected by temperature (p=0.287), acclimation training (p=0.305),
and exercise (p=0.691). Peak responses revealed no differences between environmental
temperature for LOOH (p = 0.128) or 8-ISO (p=0.273).
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Figure 2. (A) Plasma lipid hydroperoxides. Lipid hydroperoxides are expressed as lipid
hydroperoxide equivalents (µM) for exercise in a room temperature environment during the preacclimation trial (shaded bars), hot environment environment during the pre-acclimation trial
(black bars), room temperature environment during post-acclimation trial (dashed bars), and hot
environment during post-acclimation trials (white bars). (B) Plasma 8-Isoprostanes. 8Isoprostane values are expressed in standard comparison to 8-Isoprostanes protein content
(pg/mL).* Significantly different from pre-exercise values. # Significantly different from the preacclimation trial. Means are expressed ± SEM.
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Protein Damage
Biomarkers for oxidative damage - as measured by PC and 3-NT - are presented in Figure 3A and
3B. The examination of PC revealed an inexplicable effect for temperature in PC values (p<0.001);
however, no temperature x time interaction effect occurred (p=0.195). PC was also unaffected by
exercise (p=0.351) and acclimation training (p=0.393). When examining peak responses of PC, a
main effect for temperature occurred (p=0.001), but there was no temperature x time interaction
effect (p=0.437). Further, there was no effect of acclimation training (p=0.437). The peak response
of PC was significantly elevated with exercise (p=0.002). 3-NT was unaffected by environmental
temperature (p=0.253) and exercise (p=0.053). A significant difference between pre and post
acclimation trials (p=0.026) was observed, as well as a trial x time interaction effect (p<0.001).
Pairwise comparisons revealed that 3NT was higher at 2-HR following exercise after three weeks
of acclimation training in the hot environmental condition (p=0.031). Additionally, 3NT was
significantly higher at 2-HR (p=0.001) and 4-HR (p=0.009) after exercise in the room temperature
condition following a three-week period of acclimation training. Examination of peak responses
of 3-NT indicated there were no differences between environmental temperatures (p=0.204).
However, an exercise-dependent increase was observed at peak (p<0.001). Further, an effect of
trial (p=0.048) and a trial x time interaction effect (p=0.004) occurred. Pairwise comparisons
determined that peak values were significantly higher in the room temperature trial following the
three-week training period (p=0.007).
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Figure 3. (A) Protein Carbonyl values are expressed in standard comparison to protein carbonyl
equivalents (nmol/mg protein) for exercise in a room temperature environment during the preacclimation trial (shaded bars), hot environment during the pre-acclimation trial (black bars), room
temperature environment during post-acclimation trial (dashed bars), and hot environment during
post-acclimation trial (white bars). (B) Plasma Nitrotyrosine. Nitrotyrosine values are expressed
in standard comparison to nitrotyrosine protein content (ug/mL). # Significantly different from
pre-acclimation trial. † Significantly different between environmental temperatures. Means are
expressed ± SEM.
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Antioxidant Capacity
Mean responses for plasma antioxidant status assessed through the measurement of TEAC and
FRAP are presented in Figure 3A and 3B. There was no effect of environmental temperature
(p=0.0542) or acclimation training (p=0.587) on TEAC; however, an exercise effect was observed
(p<0.001). TEAC was significantly elevated at Post (p=< 0.001), 2-HR (p<0.001), and 4-HR
(p<0.001). Similarly, FRAP was unaffected by environmental temperature (p=0.370) and
acclimation training (p=0.700), but increased significantly with exercise (p<0.001). FRAP
increased at Post (p=0.001) and remained elevated at 2-HR and 4-HR (p<0.001). Peak responses
for TEAC were unaffected by temperature (p=0.449). Additionally, peak responses for FRAP were
not different between environmental temperatures (p=0.30). The peak response for both TEAC
and FRAP demonstrated a significant elevation in response to exercise (p<0.001).
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Figure 4. (A) Trolox Equivalent Antioxidant Capacity. Trolox Equivalent Antioxidant Capacity
values are expressed as Trolox equivalent antioxidant capacity equivalents (umol/L) for exercise
in a room temperature environment during pre-acclimation trial (shaded bars), hot environment
during pre-acclimation trial (black bars), room temperature environment during post-acclimation
trial (dashed bars), and hot environment during post-acclimation trial (white bars). (B) Ferricreducing Ability of Plasma. Ferric-reducing Ability of Plasma values are expressed as ascorbate
equivalents (µmol/L).* Significantly different from pre-exercise values. Means are expressed ±
SEM.
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DISCUSSION
Acute disruptions in redox balance due to exercise are beneficial for the development of exerciseinduced adaptations13, 23, 95. Importantly, previous investigations indicated that elevated core and/or
environmental temperature can increase the blood oxidative stress response to exercise23, 24, 302, 305;
however, the impact of an acclimation training period in a hot environment on the oxidative stress
response to an acute exercise session is unknown. Thus, the purpose of the current investigation
was to examine the effect of an acclimation training period (15 exercise sessions) on the blood
oxidative stress response to a single bout of exercise in a hot environment (33ºC). We hypothesized
that an acclimation training period would blunt the elevated oxidative stress response typically
seen with exercise under hot ambient temperatures. Results of the current investigation did not
demonstrate a decrease in the blood oxidative stress response to a bout of exercise following the
acclimation training period. Further, oxidative stress was not elevated in response to exercise in a
hot (33ºC), compared to room temperature (20ºC) environment.
LOOH and 8-ISO were selected as biomarkers of lipid damage for the current investigation.
Importantly, both LOOH and 8-ISO perturbations have been observed in response to exercise9, 10,
15, 17, 97, 278, 306, 307

. When examining the effect of exercise under hot ambient temperatures, Quindry

et al. 23 demonstrated that moderate-intensity aerobic exercise (60% VO2max) elicited a significant
elevation in LOOH one hour after exercise, when compared to exercise in a cold environment
(7ºC). However, when LOOH values were compared between hot (32ºC) and neutral (20ºC)
environmental conditions, no differences were observed. Additionally, McAnulty et al. did not
observe differences in the LOOH response between exercise in hot (35ºC) or neutral environments
(25ºC)24. These findings are consistent with those of the current investigation, in which no
differences in LOOH were found between one-hour of cycling at 50% Wpeak under hot (33ºC) and
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room temperature (20ºC) environmental conditions. Findings regarding isoprostane responses to
hyperthermic exercise are mixed24,

302

. Laitano et al. examined plasma isoprostanes with an

elevated core body temperature of 1°C and 6°C from baseline, and observed no significant
elevations in either of the conditions302. These findings are consistent with the current
investigation, where no differences in exercise-induced responses under hot or room temperature
conditions were observed before or after a heat-acclimation training period. However, McAnulty
et al. observed a greater elevation of F2-isoprostanes following treadmill running at 50% VO2max24.
Although no differences were found between environmental temperatures following the
acclimation training period, an effect of exercise training was observed with a greater elevation of
LOOH following 15 exercise training sessions.
Protein damage, specifically free radical-mediated damage and modification of amino acid
residues, can be quantified through measurement of PC and 3-NT308,

309

. Previous work has

demonstrated an exercise-induced increase in circulating markers of free-radical mediated protein
damage15, 100, 101, 310; however, the effects of hyperthermic exercise on protein carbonyl responses
remain unclear23, 25, 26. Results of the current study demonstrated that post-exercise PC were not
different following acute hyperthermic exercise. Our findings are in agreement with those of
Quindry et al.23, in which PC were not impacted by one-hour of exercise (60% VO2max) at hot
ambient temperature (32ºC). Further, Sureda et al. observed no differences in PC responses to 45min of treadmill exercise at 75-80% VO2max, indicating that PC responses may not be sensitive to
hyperthermic conditions when examined in these types of exercise challenges25. The current
investigation added an additional marker of protein damage, 3-NT, to provide a more holistic view
of protein damage in response to hyperthermic exercise; however, the biomarker was not altered
following exercise in either ambient temperature. In addition to acute exercise responses, the

92

current investigation examined the effect of an acclimation training period on blood oxidative
stress responses to exercise; however, due to the lack of temperature effects, it is unclear whether
an acclimation training period could blunt oxidative stress responses. Previous work examined the
impact of four-weeks of interval training under hyperthermic conditions and observed an elevation
of lipid oxidation; however, protein oxidation was blunted25. Further research is necessary to
clarify the impact of hyperthermic exercise training on protein oxidation responses to traditional
exercise training (i.e., exercise prescriptions for healthy adults) and to extended duration events
(i.e., ultramarathons, etc.).
Blood plasma concentrations of TEAC and FRAP are known to elevate with exercise under
normothermic conditions, which is representative of an altered antioxidant quenching capacity in
response to purine metabolism following fatiguing exercise10, 13, 15, 23, 90, 92, 307. Findings of the
current investigation demonstrated an exercise-induced elevation in both TEAC and FRAP
independent of the ambient temperature, which are consistent with previous literature. Regarding
hyperthermia, there are limited investigations examining TEAC and FRAP responses to exercise.
Quindry et al. examined exercise-induced responses to moderate-intensity aerobic exercise and
determined that TEAC and FRAP are elevated to a greater extent when exercise is performed in
hyperthermic conditions, indicating greater antioxidant quenching capacity23. Further, an
investigation examining the responses of reduced glutathione (GSH), oxidized glutathione
(GSSG), and superoxide dismutase (SOD) to moderate-intensity exercise observed an elevation in
antioxidant capacity302. Sureda et al. quantified plasma antioxidant status post-exercise via catalase
activity and observed greater elevations of antioxidant status following hyperthermic exercise,
further supporting the notion that exercise-induced oxidative stress in hot temperatures result in a
greater elevation of antioxidant capacity within the blood. The current investigation did not
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observe a hyperthermic-induced elevation in oxidative stress; however, elevated metrics of
antioxidant capacity were observed within both normothermic and hyperthermic environments.
Further, the current investigation was novel in the attempt to determine how exercise training in
hot environments would impact metrics of antioxidant capacity; however, because no differences
were observed between hot and room temperature environments, conclusions regarding heat
acclimation training cannot be drawn. Importantly, previous investigations examined trained
individuals at higher-exercise intensities; thus, the findings of the current study are likely attributed
to the selected population and/or the lower exercise intensity.
The current investigation employed a novel approach to examine a holistic panel of oxidative
stress, which include two biomarkers of lipid damage, protein damage, and antioxidant capacity.
Importantly, based on the current findings, an exercise training period at hyperthermic
temperatures does not blunt the blood oxidative stress responses to an acute bout of exercise.
Further, the results of the current study add to the growing body of literature regarding blood
oxidative stress responses to acute exercise under hyperthermic conditions. Biomarkers of lipid
damage, protein oxidation, and/or antioxidant capacity were not altered by acute exercise under
hyperthermic conditions within the current investigation. Future research should emphasize the
effects of various exercise training interventions (e.g., intensities and modalities) to better
understand the impact of acclimation training on the blood oxidative stress response. Additionally,
due to sample size in the current investigation, analyses of sex-dependent differences were not
powered. Future investigations should determine if there are sex-dependent differences in the
blood oxidative stress response to acute hyperthermic exercise, due to the established relationship
between estrogen concentrations and altered thermoregulatory responses, and whether heat
acclimation training offers advantages to oxidative stress responses in more extreme forms of
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exercise.
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Chapter VI: Cardiovascular and Blood Oxidative Stress Responses to Exercise and Acute
Woodsmoke Exposure in Recreationally Active Adults

ABSTRACT
Introduction: Those who work and recreate outdoors experience woodsmoke exposure during fire
season. Exercise during woodsmoke exposure undeniably harms the cardiovascular system, but
the acute physiologic and biochemical responses are understudied. The purpose of this pilot
laboratory-based study was to examine exercise during woodsmoke exposure on acute indicators
of cardiovascular function, including heart rate variability (HRV), pulse wave velocity (PWV),
blood pressure (BP), augmentation index (AIx), and blood oxidative stress. Methods: Ten
participants performed 2 moderate-intensity exercise (70% VO2max) trials (clean air 0 µg·m-3,
woodsmoke 250 µg·m-3) in a crossover design. HRV, PWV, BP, AIx, and blood oxidative stress
were measured at PRE, POST, and 90 min post-exercise for each trial. Blood oxidative stress was
quantified through lipid damage (LOOH, 8-ISO), protein damage (3-NT, PC), and antioxidant
capacity (TEAC). Results: A 45 min woodsmoke exposure combined with moderate-intensity
aerobic exercise did not result in a statistically significant difference in HRV, PWV, BP, AIx, or
oxidative stress (P>0.05). Conclusion: Despite the known deleterious effects of smoke inhalation,
moderate-intensity aerobic exercise while exposed to woodsmoke particulate matter (250 µg·m-3)
did not result in HRV, PWV, or blood oxidative stress in this methodological context. While
findings do not negate the untoward impact of woodsmoke inhalation, additional research
approaches are needed to better understand the acute effects of smoke exposure on the
cardiovascular system.

96

INTRODUCTION
Smoke inhalation from biomass combustion is a public health problem in the western United States
due to frequent and large-scale wildfires27. Health dangers are associated with biomass particulate
matter (PM) inhalation; including airborne particles ≤ 2.5 microns in diameter (PM2.5). Populations
impacted by PM2.5 include wildland firefighters (WLFF) and those who exercise outside28.
Exercise ventilatory rates elevate the inhaled PM2.5 dose, and smoke inhalation dose is proportional
to the PM2.5 concentration, duration of exposure, and ventilatory rates associated with activity311.
Accordingly, this approach for estimating woodsmoke inhalation doses is currently untested in
laboratory assessments where the acute impacts on cardiovascular function can be determined.
Long-term smoke inhalation elevates the risk for cardiovascular mortality by 0.4 to 1.0 % with an
incremental increase of only 10 µg·m-3 above the mean 24 h PM2.5 concentration29. Further,
chronic PM2.5 inhalation is associated with a reduced life expectancy and increased rates of
cardiovascular disease29. How the long-term consequences of smoke inhalation are reflected by
acute physiologic and biochemical responses to smoke inhalation are relatively understudied.
Preliminary findings in this regard indicate that pathophysiological mechanisms include
perturbations in autonomic dysregulation, mitigated cardiovascular control, systemic
inflammation and oxidative stress29. Cardiovascular and autonomic control can be quantified by
heart rate variability (HRV), pulse wave velocity (PWV), and resting blood pressure (BP). HRV
is prognostic of cardiovascular health when HRV recovery following physiologic stressors is
delayed120. In some experimental context, HRV is reduced by woodsmoke inhalation, suggesting
a concomitant decline in autonomic tone123, 312. Additionally, PWV and blood oxidative stress
provide further insight into acute physiological changes following exercise with woodsmoke
exposure.
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Accordingly, we examined the effect of exercise on acute woodsmoke inhalation using a
laboratory-based pilot investigation. Key dependent variables included metrics of cardiovascular
function (HRV, PWV) and a blood oxidative stress panel to gauge associations between
woodsmoke inhalation and cardiovascular control. PM2.5 dosing. This approach was based on prior
investigations which demonstrated physiologic perturbations at PM2.5 inhalation dosages of 250
µg·m-3

92, 94

; representing “Very Unhealthy” according to the Air Quality Index (AQI). We

hypothesized that moderate-intensity exercise during a 45 min woodsmoke exposure at 250 µg·m3 would decrease HRV, elevate PWV, and amplify blood oxidative stress.
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METHODS
University of Montana institutional review board and participant informed consent was obtained
prior to data collection. Inclusion criteria dictated a VO2max of ≥ 40.0 mL·kg-1·min-1. The presence
of limiting orthopedic problems, smokers (previous 6 months), or diagnosed cardiovascular,
pulmonary, or metabolic diseases (determined by the PAR-Q) resulted in exclusion from the
study313.
The study utilized a crossover design. Data collection started between 0600 and 0900 on 3 occasions
with a minimum of 7 days separating visits to allow for a wash-out period following smoke
exposure. Participants fasted for 10 h, abstained from alcohol and exercise for 24 h, and avoided
caffeine for 12 h prior to testing. The first laboratory visit consisted of study orientation, body
composition measurements, and a VO2max cycling test. The 2 exposure trials were performed in
filtered air (0 µg·m-3) and woodsmoke (250 µg·m-3) during 45 min of cycling at 70% VO2max.
Measurements of HRV, PWV, augmentation index (AIx), BP, pulmonary function (PF), and blood
sampling for oxidative stress were conducted before (PRE), immediately following (IPE), and 90
min post-exercise (90-P) (Figure 1). The battery were completed within 30-45 minutes. All IPE
measurements were collected within 45 min of the cessation of exercise, and all 90-P
measurements were collected between 90-120 min following the completion of exercise.

99

Filtered Air (0 g/m3 ) or Woodsmoke Exposure (250 g/m3)

⋅⋅⋅ Recovery ⋅⋅⋅

45-min at 70% VO2peak

Pre

Venipuncture

Heart Rate Variability

Post

90-min Post

Pulse Wave Velocity

Figure 1. Experimental design. A crossover design was used for the investigation to examine
differences in cardiovascular and oxidative responses with exposure to either filtered air (0 µg·m3)
or woodsmoke (250 µg·m3).
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Body composition was measured via hydrostatic weighing (Exertech, Dresbach, MN). Values
were corrected for residual lung volume (residual lung volume=(0.01115•Age)+(0.019•Height)–
2.24)

92

, and body volume estimates were converted to percent body fat utilizing the Siri

Equation314. The VO2max test was performed on a cycle ergometer (Velotron, Spearfish, SD)
following a 5 min warmup at 50 W, and transitioned into a ramp protocol (resistance +1 Watt/2 s
until <60 rpm occurred). Expired gas was sampled using indirect calorimetry (Cosmed Quark
CPET, Concord, CA).
Exposure trials were conducted at the Inhalation and Pulmonary Physiology Core at the Center for
Environmental Health Sciences at the University of Montana. Fires were generated using an inline inhalation system woodstove stoked with Western Larch (Larix occidentalis Nutt). Fires were
prepared 30 min prior to exercise using 1 kg of wood and kindling and stoked with 300 g of wood
every 15 min throughout the trial.
Participants kept a nutritional log for 24 h prior to each session and repeated dietary practices for
each trial. Participants were exposed to filtered air (0 µg·m-3) and woodsmoke (250 µg·m-3) in a
crossover design while exercising. Exposures were alternated and conducted in a blinded fashion.
A third-party core-laboratory researcher was aware of the exposure condition until the conclusion
of data collection. PM2.5 levels were monitored continuously and woodsmoke concentrations were
maintained with PM2.5 monitors (DustTrak, TSI, Model 8530, Shoreview, MN). Participants
breathed through a modified mask to deliver woodsmoke. Exercise consisted of cycle ergometry
at 70% VO2max (Monark 828E, Langley, WA) for 45 min. HRV, PWV, AIx, BP, PF, and blood
samples were collected at the PRE, IPE, and 90-P. PRE and 90-P measurements were collected in
the following order: HRV, PWV, AIx, BP, PF, and blood samples. IPE measurements were
collected in the same order, except the blood samples occurred prior to HRV measurements and
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immediately after the cessation of exercise. When collecting IPE and 90-P measurements,
researchers were blind to the pre-exercise values until the time of analysis.
HRV indices included the root mean square of successive differences (RMSSD), high frequency
(HF), low frequency (LF), and the ratio (LF:HF), as based on established methods120,

315

.

Participants tested in a quiet, dimly lit room in supine position on an examination table. ECG
electrodes were placed in a modified limb lead configuration using an iWorx system (iWorx,
Dover, NH). Three 10 min recordings were obtained (PRE, IPE, and 90-P), and the last 5 min
segment was used for analysis on Kubios Software (Kubios, V 2.2, Joensuu, Finland). As an a
priori decision, all four HRV metrics would need to be altered by exposure to be considered
physiologically significant due to the interrelational nature of the assessment.
PWV, AIx, and BP were obtained using the SphygmoCor XCEL device (Atcor Medical, Sydney,
Australia) after 10 min of supine rest. Right side measurements were recorded until 3 values were
obtained within 0.5 m·s-1. The femoral cuff was placed around the upper thigh and carotid pulse
was identified using applanation tonometry. PWV between the carotid and femoral arteries was
calculated based on the arterial stiffness formula: PWV=distance (m)/transit time (s).
Blood was collected via venipuncture through an antecubital vein. Samples were collected in 10mL heparinized tubes and immediately centrifuged at 1,500 rpm for 15 min at 4°C, aliquoted, and
stored at -80 °C until assayed.
A panel of blood oxidative stress markers was measured for lipid- (lipid hydroperoxides, LOOH,
8-isoprostane, 8-ISO) and protein-damage (protein carbonyls, PC and 3-nitrotyrosine, 3-NT).
Trolox equivalent antioxidant capacity (TEAC) was utilized as a marker of antioxidant status.
Samples were subjected to a single freeze-thaw cycle and were kept on ice in the dark to prevent
redox alterations.
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TEAC assays were performed to measure antioxidants scavenging of 2,2´-azinobis-(3-ethylbenzo-thiazoline-6-sulfonic acid) radical anions using a colorimetric reaction. Calculated TEAC
values from unknown samples were compared to standard reactions with the water-soluble vitamin
E analogue Trolox316.
Plasma LOOH were measured by the ferrous oxidation-xylenol orange assay using absorbance
spectroscopy at a wavelength of 595 nm and compared with cumene hydroperoxide standards317.
8-ISO was assessed using a commercially available enzyme-linked immunosorbent assay kit
according to the manufacturer’s guidelines (Cayman Chemical, Ann Arbor, MI).
Oxidative protein damage were quantified using absorbance spectroscopy according to the
established methods of Bradford318, followed by a commercially available enzyme-linked
immunosorbent assay kit (Enzo Life Sciences, Farmingdale, NY and Cell Biolabs INC, San Diego,
CA).
PF, a secondary variable, was assessed by forced vital capacity (FVC) and maximal voluntary
ventilation (MVV, performed for 12 s) tests using a spirometer (MIR Spirobank, Elicott City, MD),
with participants tested in the seated position. Participants were provided with verbal
encouragement during PF tests. Data were analyzed using the WINSPIRO Pro software (Version
7.8, Ellicott City, MD).
A series of exposure x time repeated measures analysis of variance (ANOVA) with a Bonferroni
correction were performed to compare the differences in mean values. The General Linear Model
(GLM) function was used in statistical software (V.25.0, SPSS Inc., Chicago, IL) for all analyses.
A criterion alpha level of P≤0.05 was used to determine statistical significance. Data are reported
as mean±standard deviation. When analyzing HRV, to satisfy the normality assumption, a natural
logarithmic transformation was performed on RMSSD, HF, and LF, and were reported as
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lnRMSSD, lnHF, and lnLF prior to statistical analysis. The aim of the study was to determine if
woodsmoke exposure during moderate-intensity exercise would result in deleterious effects on
variables of cardiovascular function.
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RESULTS
Ten active individuals (male: n=7, female: n=3) completed the study. Participant characteristics
are presented in Table 1.
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Table 1. Participant Characteristics
Characteristic

n=10

Males (n=7)

Females (n=3)

Age (yrs)

30 ± 11

31 ± 13

27 ± 2

Height (cm)

176 ± 9

182 ± 5

165 ± 1

Weight (kg)

76 ± 12

83 ± 7

62 ± 1

Body Fat (%)

19 ± 9

17 ± 9

24 ± 7

VO2peak (mL∙kg-1∙min-1)

44 ± 4

46 ± 4

41 ± 1
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No interaction effect was observed for HR (P=0.965) or recovery of HR (P=0.784). No statistically
significant difference was observed in HR during the exposure trials (P=0.541) or during the
recovery of HR (P=0.734). HR was elevated similarly during the experimental trials. HR responses
across the trial (Table 2), when comparing rest to IPE and 90-P, indicated a time effect whereby
IPE was elevated (P<0.001). Average HR values returned to baseline at 90-P (P=0.06).
HRV was quantified for: lnRMSSD, lnHF, lnLF, and LF:HF (Table 2). Analysis of lnRMSSD,
lnHF, lnLF, and LF:HF ratio indicated no interaction effects (lnRMSSD: P=0.912, lnHF: P=0.148,
lnLF: P=0.905, LF:HF: P=0.109) and no between-trial differences (lnRMSSD: P=0.685, lnHF:
P=0.843, lnLF: P=0.275, LF:HF: P=0.057); however, a main effect of time was observed
(lnRMSSD: P=0.001, lnHF: P=0.003), indicating that parasympathetic activity was reduced in
response to exercise. A significant reduction occurred at IPE (lnRMSSD: P=0.016, lnHF:
P=0.005), with a recovery of both indices by 90-P (P>0.99). lnLF demonstrated a time effect
(P=0.039). At 90-P, lnLF was lower than IPE (P=0.026) and pre-exercise values. Finally,
examination of the LF:HF ratio indicated no time effect (P=0.189).
Analysis of PWV and AIx (Table 2) indicated no interaction effect (PWV: P=0.909, AIx:
P=0.626), trial effect (PWV: P=0.856, AIx: P=0.136) or time effect (PWV: P=0.975, AIx:
P=0.192), indicating that these markers were not statistically different. No statistical difference
was observed in Brachial BP was unaffected by trial (SBP: P=0.883, DBP: P=0.769) or time (SBP:
P=0.293, DBP: P=0.705).
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Table 2. Variables of Cardiovascular Function
Marker

Filtered Air
Trial

Woodsmoke
Trial

Main Effect
P

Interaction Effect
P

53±7
68±9
57±8

49±11
72±10
55±9

0.734

0.784

4.3±0.6
3.6±0.6
4.2±0.5

4.3±0.5
3.6±0.5
4.3±0.6

0.685

0.912

7.5±1.4
6.0±1.3
7.2±1.1

7.3±1.1
5.7±1.3
7.5±1.3

0.843

0.148

Mean±SD
Heart rate (bpm)
PRE
IPE
90-P
lnRMSSD (ms)
PRE
IPE
90-P
lnHF (ms2)
PRE
IPE
90-P

lnLF (ms2)
PRE
7.3±1.2
7.4±1.2
0.275
0.905
IPE
6.4±1.2
6.6±0.9
90-P
7.2±1.1
7.4±0.9
LF:HF
PRE
1.0±0.5
1.2±1.0
0.057
0.109
IPE
2.5±1.8
4.2±3.6
90-P
1.9±1.6
1.7±1.3
PWV (m/s)
PRE
5.9±1.3
5.4±1.3
0.856
0.909
IPE
5.8±1.4
5.8±1.2
90-P
6.1±1.2
6.0±1.3
Augmentation Index (%)
PRE
7.3±5.5
3.6±8.9
0.136
0.626
IPE
9.2±12.5
7.7±8.0
90-P
5.7±3.0
3.6±9.7
90-P, 90 min postexercise; HF, high frequency; IPE, immediately after exercise; LF, low frequency; PRE, before exercise;
PWV, pulse wave velocity; RMSSD, root mean square of successive differences
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Blood oxidative stress (Table 3) analyses indicated no interaction- (P=0.699) trial- (P=0.505) or
time-effect (P=0.711) on PC, indicating that the protein damage marker was not statistically
different with exposure or exercise. 3-NT and LOOH data revealed no interaction- (3-NT:
P=0.784, LOOH: P=0.126) or time-effect (3-NT: P=0.426, LOOH: 0.159); however, a main effect
for trial was observed (3-NT: P=0.046, LOOH: P=0.011). 8-ISO demonstrated no interaction
effect (P=0.800), trial effect (P=0.296) or time effect (P=0.158). Antioxidant capacity
demonstrated a time effect (P=0.009); however, no effect of trial (P=0.068) or interaction effect
(P=0.234). TEAC was elevated at IPE (P=0.002) and 90-P (P=0.003). Similarly, for blood
antioxidant potential, there was a time effect (P=0.026), with an elevation at IPE (P=0.003) that
returned to pre-exercise values by 90-P (P=0.06).
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Table 3. Variables of Oxidative Stress
Marker
Protein Carbonyl (nmol·mg-1)
PRE
IPE
90-P
3-Nitrotyrosine (µg·mL-1)
PRE
IPE
90-P
Lipid Hydroperoxides (µmol·L-)
PRE
IPE
90-P

Filtered Air
Trial

Woodsmoke
Trial
Mean±SD

Main Effect
P

Interaction Effect
P

0.18±0.03
0.20±0.03
0.18±0.03

0.17±0.02
0.17±0.02
0.17±0.02

0.505

0.699

3.4±2.1
3.8±2.4
3.05±2.3

3.0±1.6
3.3±2.3
2.8±1.6

0.426

0.784

1.7±1.6
2.5±2.1
2.6±1.9

3.3±1.6
4.0±2.0
3.2±2.1

0.159

0.126

8-Isoprostane (pg·mL-1)
PRE
18.8±9.6
22.2±12.2
0.296
0.800
IPE
24.9±12.5
31.3±26.1
90-P
24.3±13.5
28.8±23.6
-1
TEAC (µmol·L )
PRE
112.7±12.3
109.9±10.4
0.068
0.234
IPE
135.5±14.8
118.4±19.8
90-P
125.2±16.3
120.9±16.4
90-P, 90 min postexercise; IPE, immediately after exercise; PRE, before exercise; TEAC, Trolox equivalent antioxidant
capacity.
* Significant main effect

110

The secondary PF data are presented in Table 4. For FVC there was no interaction- (P=0.700),
trial- (P=0.632) or time-effect (P=0.555). Similarly, FEV1 and FEV1/FVC exhibited no
interaction-(FEV1: P=0.373, FEV1/FVC: P=0.464), trial- (FEV1: P=0.940, FEV1/FVC: P=0.694)
or time effect (FEV1: P=0.406, FEV1/FVC: P=0.723). MVV also demonstrated no interaction(P=0.800), trial- (P=0.667) or time-effect (P=0.068).
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Table 4. Pulmonary Function Variables

Variable

Woodsmoke Trial

Filtered Air Trial

n=10

n=10
Mean±
±SD

FVC (L)
PRE

5.07±0.28

5.04±0.25

IPE

5.03±0.26

5.10±0.25

90-P

5.02±0.26

5.07±0.25

PRE

4.03±0.21

4.02±0.19

IPE

4.09±0.22

4.05±0.21

90-P

4.05±0.20

4.09±0.20

PRE

80±2

80±2

IPE

81±2

80±2

90-P

81±2

81±1

PRE

146±12

146±10

IPE

159±14

159±10

90-P

141±12

149±11

FEV1 (L)

FEV1/FVC (%)

MVV (L/min)

90-P, 90 min postexercise; FVC, forced vital capacity; FEV1, forced expiratory volume in 1s; IPE, immediately
after exercise; MVV, maximal voluntary ventilation; PRE, before exercise
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DISCUSSION
Long-term woodsmoke inhalation is damaging to the cardiovascular system, but the acute effects
of smoke exposure are not well understood. Recreational exercisers, WLFF, and persons with
chronic outdoor exposure during wildfire season are at risk for long-term cardiovascular health
consequences92, 94. Accordingly, using a laboratory-based pilot investigation, we examined the
acute effects of exercise and woodsmoke-inhalation (PM2.5 250µg·m-3) on the primary variables
of HRV, PWV, and oxidative stress. Indeed, inhalation of concentrated smoke (250 µg·m-3) elicits
inflammation and oxidative stress response known to be deleterious to cardiovascular health17, 94.
Despite the fact that chronic smoke inhalation is detrimental to long-term cardiovascular function,
our acute physiologic (HRV, PWV) and biochemical blood markers of oxidative stress were not
statistically different between the smoke inhalation and filtered air challenges. This unexpected
finding highlights the scientific importance of identifying acute physiological and biochemical
metrics that may better inform the long-term consequences of woodsmoke inhalation. We interpret
these negative findings to have been influenced by the experimental context in which the
laboratory-based investigation was conducted, attributing potential causation to the following
methodological factors: 1) examination of a population - young, apparently-healthy subjects –
presumably being more resilient to this smoke inhalation challenge, 2) methodological constraints
(e.g., sampling time points and selection of biochemical variables), 3) small sample size, and 4)
insufficient dose, which did not capture perturbations due to smoke.
A key dependent variable of this investigation was HRV. Inability to maintain a high resting HRV,
or exhibiting delayed rebound following a stressor, predicts an increased risk for mortality and
sudden cardiac death121. Previous longitudinal findings demonstrated decreased HRV in those
regularly exposed to woodsmoke particulate matter in occupational settings312. Notably,
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depression of HRV following acute smoke inhalation signals problematic responses to reoccurring
exposures. Accordingly, we examined HRV following a single woodsmoke challenge in
apparently-healthy research participants to examine the potential of declines in HRV that could
inform recurrent exposures. Results indicated no statistically significant alterations existed for
HRV (lnRMSSD, lnHF, lnLF, LF:HF) for up to 90 min after exposure, a finding that does not
discount the deleterious effects of acute smoke inhalation. In contrast to our findings, HRV
(SDNN, RMSSD, HFnu, and pNN50) was systematically reduced in fourteen subjects following
a 3 h intermittent exercise session with exposure at ~300 µg·m-3 123. This divergent outcome may
indicate that the duration of smoke exposure within the current study was insufficient to elicit
changes, highlighting the need to identify woodsmoke exposure (duration and/or PM2.5
concentration) threshold that perturbs cardiovascular function. Moreover, age, fitness level, and
health status - and the duration of HRV assessment (e.g., longer sampling periods) – should be
examined. Previous work demonstrated that HRV is acutely depressed in woodsmoke-exposed
elderly populations319. Additionally, post-exercise parasympathetic rebound is enhanced in fit and
healthy populations120, suggesting our sample may have exhibited preserved HRV as compared to
a sedentary population. Given the disparate outcomes of this study as compared to others, future
investigations should consider longer duration baseline- and post-intervention HRV analyses to
confirm or refute the current findings.
PWV is predictive of elevated cardiovascular event risk320, although prior studies have examined
the effects of woodsmoke exposure on PWV with equivocal results123,

127

. Our findings

demonstrated that PWV was not statistically different by a 45 min exercise session with a
woodsmoke exposure at 250 µg·m-3, a finding that is similar to a prior investigation reporting
negative PWV outcomes 1 h post-exercise with an exposure at 1000 µg/m3
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127

. However, PWV

has been demonstrated to increase for up to 25 min after a 3 h bout of exercise and an exposure of
300 µg·m-3 123. Collectively, PWV may be more responsive to exposures between 1 h and 3 h in
duration123, 127, 128. In support, a recent study examined the effects of woodsmoke exposure at 3
different concentrations (100 µg·m-3, 250 µg·m-3, and 500 µg·m-3) under resting conditions,
finding that PWV was elevated 24 h after all exposures128. The magnitude of the elevation was
similar across all 3 concentrations, signifying that PWV may not respond to smoke in a dosedependent manner. AIx is an additional variable of arterial stiffness that is associated with elevated
cardiovascular disease risk321, 322. Our data demonstrated that AIx was not statistically different
between the smoke exposure and filtered air trials for this healthy population. Previous research
indicated AIx was elevated at a slightly higher dose of PM2.5 (~314 µg·m-3) following 3 h of
exposure with intermittent exercise123; however, this response was not replicated when intermittent
exercise was performed for 1 h at a PM2.5 dose of ~1000 µg·m-3 127. While these mixed findings
cannot be explained currently, there is a proposed association between elevated oxidative stress
and increased arterial stiffness, indicating they may occur in tandem323. Therefore, the exercise
and/or exposure may require a yet-to-be determined duration and/or intensity threshold to elicit a
measurable change in arterial stiffness.
All post exercise oxidative stress variables were not statistically different between woodsmoke
and filtered air exposures as examined at these selected time points in healthy research participants.
Previous research has demonstrated that a 1.5 h treadmill bout with woodsmoke exposure at 500
µg·m-3 resulted in an elevation of 3-NT immediately after exercise, but did not rise with an
exposure at 250 µg·m-3 92. In agreement with prior work, the current study indicated no statistically
significant elevation following the 45 min of exercise and smoke (250 µg·m-3), suggesting that 3NT may respond dose-dependently. Moreover, our negative findings for PC are consistent with

115

the previously mentioned study, where PC was also unaltered by woodsmoke exposure at both 250
µg·m-3 and 500 µg·m-3 92. Importantly, these negative findings do not negate the detrimental impact
of smoke inhalation on protein damage markers. By extension, we may have simply missed the
spike in PC, as this marker has been shown to peak hours or days after the stressor11, 13; thus, the
selected sampling time points used currently may not have captured the peak response.
Lipid oxidative damage was quantified via plasma LOOH and 8-ISO. Previous research
demonstrated no elevation of LOOH following a 1.5 h woodsmoke exposure during low-intensity
exercise92; however, 8-ISO was elevated immediately following exercise at 2 inhalation doses (250
µg·m-3 and 500 µg·m-3). Moderate-intensity exercise (70% VO2max cycling) was selected
currently to elevate ventilatory rates; however, LOOH and 8-ISO were not statistically different
following exercise with PM2.5=250 µg·m-3. Nonetheless, LOOH is most responsive to highintensity exercise324, suggesting that our exercise modality and PM2.5 dose were insufficient to
elicit elevations.
TEAC was also examined following exercise and woodsmoke exposure, however, it was not
statistically different between woodsmoke and filtered air exposures. Previous work examined the
TEAC response to higher woodsmoke exposure (average 375 µg·m-3) during a 1.5 h bout of
treadmill walking and found TEAC was elevated in response to woodsmoke exposure92. However,
when the prior 250 µg·m-3 exposure trial was examined alone, TEAC was not elevated in response
to the exposure, in agreement with our TEAC values following a 45 min exposure at 250 µg·m-3.
These collective findings indicate that TEAC may be responsive to woodsmoke exposure in a
smoke-dose-dependent manner. Overall, we did not observe a statistically significant increase in
post exercise oxidative stress between smoke inhalation and filtered air, which suggests that these
markers respond differently based on exposure dose and duration, in addition to exercise intensity.
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We interpret this finding to indicate that our methodological approach (e.g., exercise dose,
population, and sampling time points) did not elicit oxidative changes, a finding that would have
otherwise been present in multiple markers across our oxidative stress panel.
PF was examined as a secondary group of variables in our healthy sample population. Finding
indicated that FVC, FEV1, and MVV were not statistically different for either exercise or exposure.
Importantly, these findings are consistent with previous work which demonstrated no changes in
FVC, FEV1, or MVV following a 1.5 h exposure during treadmill walking94, and highlights the
fact that while smoke inhalation is clearly detrimental to long-term health325, acute physiologic
responses to exposure may not always result.
Limitations
Study limitations include the nature and size of the sample. Due to the age range, fitness level, and
overall health of the examined sample, inference of these results is limited proportionately. Thus,
it is plausible that these methods applied to more susceptible populations (e.g., aged, chronic
conditions, etc.) may have produced alternative outcomes for our grouped outcome measures of
HRV, PWV metrics, and oxidative stress markers. Further, female participants were
underrepresented within this study (n=3) and the potential confounding influence of hormonal
alterations (e.g., menstrual cycle and/or contraceptive use) were not considered. For this reason,
conclusions about female-specific responses cannot be drawn from the results of the current study.
Furthermore, the dose of woodsmoke exposure may have been insufficient to elicit adverse effects
on the selected variables. The study design was predicated on the notion that a seven-day washout
period is sufficient for the assessment of acute physiologic responses to smoke exposure, an
assumption that should be confirmed with future investigations. Additionally, the study examined
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only one modality, duration, and intensity of exercise, limiting the application of these findings to
a similar exercise.
Conclusions
Chronic woodsmoke exposure is linked to negative health effects on cardiovascular control and
oxidative stress, although the influence of acute smoke inhalation effects are not well defined. The
current study quantified the acute effects of 45 min exercise during woodsmoke exposure (250
µg·m-3) on markers of HRV, arterial stiffness and oxidative stress; however, there were no
statistically significant differences observed as compared to filtered air. We interpret the negative
findings of the current study to have been limited by the experimental context in which the
laboratory-based study was conducted. Future research should examine the threshold for duration,
dose, and/or frequency of smoke exposure needed to produce acute perturbation in these
parameters. Moreover, the health and fitness status of the investigated population may alter the
exposure thresholds, meaning that participant age, training status, medical conditions, and sexdependent differences should also be considered in future study designs.
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Chapter VII: Home-based and Traditional Cardiac Rehabilitation Programs in a Rural
Setting: A Retrospective Study
ABSTRACT
Cardiac rehabilitation is a prescribed exercise intervention that reduces cardiovascular mortality,
secondary events, and hospitalizations. Home-based cardiac rehabilitation (HBCR) is an
alternative method that overcomes barriers to participation, such as travel distance and
transportation issues. To date, comparisons of HBCR and traditional cardiac rehabilitation (TCR)
are limited to randomized control trials, which may influence outcomes due to supervision that
occurs with clinical research investigations. PURPOSE: Coincidental to the Covid-19 pandemic,
to investigate the effectiveness of HBCR to improve exercise capacity (peak metabolic
equivalents, peak METs), resting heart rate (RHR), resting systolic (SBP) and diastolic (DBP)
blood pressure, body mass index (BMI), and depression outcomes (PHQ-9). METHODS: A
retrospective analysis examined TCR and HBCR cardiac rehabilitation at St. Patrick’s Hospital
during the COVID-19 pandemic (October 1st, 2020 and March 31st, 2022). Key dependent
variables were quantified at baseline (Pre) and discharge (Post). Completion was determined by
participation in 18 monitored exercise sessions for TCR and 4 monitored exercise sessions for
HBCR. RESULTS: Peak METs increased at Post in both TCR and HBCR (p < 0.001); however,
TCR resulted in greater improvements (p = 0.034). PHQ-9 scores significantly improved (p <
0.001). SBP and BMI did not improve with rehabilitation (SBP: p = 0.185, BMI: 0.355). DBP and
RHR significantly increased at Post (DBP: p = 0.003, RHR: p = 0.032). No association between
intervention type and program completion was observed (p = 0.172). CONCLUSIONS: Peak
METs and depression outcomes (PHQ-9) improved with TCR and HBCR. Improvements in
exercise capacity were greater with TCR; however, HBCR is a suitable alternative for those
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experiencing barriers to entry in a traditional program, an outcome that may have been essential
during the first 18 months of the Covid-19 pandemic.
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INTRODUCTION
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality within the United
States31,

33

. Exercise is a well-established treatment that reduces cardiovascular mortality,

secondary events, hospital admissions, and improves quality of life40, 43, 326. Cardiac rehabilitation
is the prescribed exercise intervention for those referred after a cardiovascular event or diagnosis39,
40

. Health benefits of cardiac rehabilitation are well-established; however, the programs are

underutilized and alternative methods of rehabilitation are essential to increase participation41.
Lack of time, transportation issues, and travel distance are commonly reported barriers to
enrollment and completion42, 68, 70. Home-based cardiac rehabilitation (HBCR) is an alternative
approach purported to addresses reported barriers. Overcoming barriers to entry and completion is
critical to increase patient engagement in cardiac rehabilitation and the achievement of the healthrelated benefits.
Randomized-controlled trials have demonstrated that HBCR can improve cardiovascular healthrelated outcomes (e.g., exercise capacity)252, 253, 255-257, 259, 262, 263, 271. However, well-controlled
trials require thorough patient supervision, and it is well-established that supervised exercise
programs increase adherence276. Thus, it is essential to evaluate the effectiveness of HBCR in an
organic, translational manner without the influence of study-based supervision. The primary
purpose of this retrospective study was to investigate the effectiveness of HBCR to improve
indicators of cardiovascular health and/or risk factors (peak metabolic equivalents, peak METs;
resting heart rate, RHR; systolic blood pressure, SBP; diastolic blood pressure, DBP; body mass
index, BMI) without the supervision required with randomized-controlled trials. Additionally,
depression is experienced by 20-45% of patients following a cardiac event, and depression is a
known challenge to lifestyle modification237, 240. Moreover, depression is recognized as significant
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independent risk factor for cardiovascular morality by the American Association of Cardiovascular
and Pulmonary Rehabilitation240. For this reason, a score of depressive symptoms, as measured by
the Patient Health Questionnaire-9 (PHQ-9), was selected as the secondary outcome of the
investigation.
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METHODS
All data were collected from the St. Patrick’s Hospital data registry for this retrospective study. A
data use agreement was formalized between the Cardioprotection Laboratory at the University of
Montana and the International Heart Institute of St. Patrick’s Hospital/Providence Health Care
System. The University of Montana Institutional Review Board issued an exemption letter for the
use of the anonymized data from the registry. Data were collected for all patients who enrolled and
completed the cardiac rehabilitation program between October 1st, 2020 and March 31st, 2022,
which coincided with the COVID-19 pandemic. Information collected from the data registry
included demographic information, medical diagnoses, smoking history, COVID-19 vaccination
and infection information, exercise capacity (Peak METs), height, weight, BMI, and outcomes of
depression (PHQ-9). Data were recorded at the time of enrollment (Pre) and discharge (Post).
Patients
Patients with a cardiovascular disease and/or event that resulted in referral to the St. Patrick’s
Hospital cardiac rehabilitation were included. Study inclusion was dependent on program
enrollment and attendance for the initial intake appointment.
Intervention
Patients were given the self-selecting option to enroll in TCR or HBCR. All patients, regardless of
which program was selected, were encouraged to attend nutritional counseling and educational
classes offered as part of the cardiac rehabilitation programs. The TCR program required
completion of 18 monitored exercise sessions (1-3 days per week). Patients were encouraged to
meet the physical activity guidelines of 150 min·wk-1 outside of their supervised cardiac
rehabilitation sessions. On-site exercise training sessions were individualized based upon each
patient’s individual exercise capacity and/or interest (e.g., resistance training). All sessions
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included some combination of a warm-up, cool-down, aerobic activity, and resistance training.
The HBCR program required four monitored on-site exercise sessions. Patients that self-selected
into HBCR were encouraged to engage in 150 min·wk-1 of moderate-intensity activity each week.
Health coaching was conducted via weekly phone calls with an exercise specialist.
Outcomes
Exercise Capacity
Exercise capacity was quantified via peak metabolic equivalents (METs). Quantification of peak
METs occurred during the supervised exercise session that took place after the initial intake
appointment. Peak METs was estimated utilizing the maximal exercise workloads achieved during
the exercise training session.
Resting Heart Rate and Blood Pressure
RHR, SBP, and DBP were recorded at the beginning of the patient’s first (Pre) and last (Post)
exercise session. All measurements were taken with the patient in a seated position. RHR was
quantified via electrocardiogram. SBP and DBP were measured by trained hospital staff members.
Body Mass Index
The height and weight of patients were measured by trained hospital staff on the date of enrollment
in the cardiac rehabilitation program (Pre) and at the time of discharge (Post). BMI was calculated
by dividing the patient’s weight by height (BMI = weight (kg) / height (m2).
PHQ-9
The 9-item Patient Health Questionnaire (PHQ-9) was administered at the time of enrollment (Pre)
and program completion (Post) to assess outcomes of depression. The PHQ-9 is a validated
assessment tool for the detection of depression with a reported Cronbach’s

of 0.81 in cardiac

rehabilitation patients241, 327. Questions on the PHQ-9 pertain to a patient’s interest/pleasure in
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doing things, feelings of depression and/or hopelessness, sleeping difficulties, energy levels, selfperception and/or feelings of failure, concentration difficulties, slow speech or restlessness, and
thoughts of self-harm. Responses to the questions are rated on a scale of 0-3, with 0 representing
“not at all,” 1 representing “several days,” 2 representing “more than half the days,” and 3
expressing the patient experienced the symptom “nearly every day.” The responses to the questions
are summed for the final score. Scores range from 0-27, and are categorized as mild (≥ 5),
moderate (10-14), moderately severe (15-19), and severe (20-27) depression.
Statistical analyses
To assess the effect of TCR and HBCR programs on health outcomes, 2 x 2 (intervention x time)
repeated measures analysis of variance (ANOVA) with a Bonferroni correction were used to
compare Pre and Post data for peak METs, RHR, SBP, DBP, BMI, and PHQ9. If an interaction
effect occurred, the interaction was further analyzed using an independent samples t-test.
Assessment of association between the selected cardiac rehabilitation program and program
completion was evaluated using the Chi-square test. Statistical significance was set to an alpha ≤
0.05, a priori. Data are reported as mean ± SD. All data analyses were conducted with the SPSS
software package (IBM, Version 28.0).
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RESULTS
A total of 389 patients were identified from the St. Patrick’s Hospital Data Registry based upon
program enrollment dates. Patients self-selected into the TCR program (n = 335) or the HBCR
program (n = 54). Of the 389 patients, 197 patients completed the required number of sessions
(TCR: n = 165, HBCR: n = 32). Importantly, no association between the type of intervention and
completion were observed (p = 0.172). The TCR group averaged 31 ± 7 supervised on-site sessions
with an intervention length of 125 ± 62 days. HBCR patients completed an average of 7 ± 6
supervised on-site sessions, 8 ± 5 weekly phone calls, and the intervention length averaged 141 ±
71 days. Unsupervised exercise was not quantified for the HBCR group. Of the 32 individuals that
self-selected into HBCR, 26 reported they selected HBCR due to travel distance (~81%), 3
reported it was due to copay issues (~9%), 2 patients wanted to exercise on their own (~6%), and
1 selected HBCR due to concerns related to COVID-19 (~3%). Baseline demographic data are
presented in Table 1. Patient medical diagnoses, comorbidities, and smoking history are presented
in Table 2.
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Table 1. Patient Demographics

TCR

P Value

HBCR
N = 165

N = 32

71 ± 10

71 ± 14

0.425

Height, m

1.72 ± 0.09

1.73 ± 0.11

0.165

Weight, kg

89.3 ± 20.2

88.6 ± 18.2

0.499

Male, n(%)

118(72)

21(66)

47(28)

11(34)

153(92.7)

30(93.8)

American Indian or Alaska Native

6(3.6)

0(0)

Asian

1(0.6)

0(0)

Other/Unknown

5(3.1)

2(6.2)

155(94.0)

27(84.4)

Hispanic or Latino

1(0.6)

0(0)

Unknown

9(5.4)

5(15.6)

Age, yr

Female, n(%)
Race, n(%)
White

Ethnicity, n( %)
Not Hispanic or Latino

Data are presented as mean ± SD
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Table 2. Patient diagnoses, comorbidities,

TCR

HBCR

medications, and smoking habits
N = 165

N = 32

Angina

3(2)

0(0)

Aortic aneurysm, dissection, or repair

8(5)

0(0)

20(12)

7(22)

CAD

2(1)

0(0)

HF

8(5)

0(0)

Ischemic cardiomyopathy

1(1)

0(0)

13(8)

4(13)

5(3)

0(0)

50(30)

8(25)

STEMI

11(6)

1(3)

TAVR

24(15)

7(22)

Valve replacement or repair

19(12)

5(15)

Hypertension

116(70)

23(72)

Dyslipidemia

150(90)

25(78)

48(29)

9(28)

144(87)

29(91)

45(27)

10(31)

Beta-blocker

127(77)

20(63)

Clopidogrel

72(44)

9(28)

148(90)

26(81)

11(6)

3(9)

Past

75(46)

19(59)

Never

75(46)

10(32)

4(2)

0(0)

Referring diagnosis, n(%)

CABG

NSTEMI
PAD
PCI

Comorbidities, n(%)

Diabetes Mellitus
Medications, n(%)
Aspirin
ACE-inhibitor

Statin
Smoker, n(%)
Current

Unknown
a

Data are presented as mean ± SD

b

Abbreviations: CABG, coronary artery bypass graft; CAD, coronary artery disease; HF, heart failure; NSTEMI,

non-ST-elevation myocardial infarction; PAD, peripheral artery disease; PCI, percutaneous coronary intervention;
STEMI, ST-elevation myocardial infarction; TAVR, transcatheter aortic valve replacement
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Peak METs data was available in a subsample of TCR (n = 151) and HBCR (n = 18) patients. A
significant effect of time (p < 0.001) and a time*intervention interaction effect (p = 0.001) was
observed. Peak METs significantly increased following cardiac rehabilitation in both groups (p <
0.001); however, TCR resulted in a greater increase in Peak METs (p = 0.034). BMI and RHR
data were available for all TCR (n = 165) and HBCR (n = 32) patients. BMI was unchanged by
cardiac rehabilitation in both groups (p = 0.355). RHR significantly increased at Post (p = 0.032).
Additionally, SBP and DBP data was available for all HBCR patients (n = 32) and a subsample of
TCR patients (n = 163). SBP did not change with cardiac rehabilitation (p = 0.185); however, DBP
significantly increased at Post (p = 0.003). PHQ9 scores were available in a subsample of TCR
patients (p = 157) and HBCR patients (n = 28). PHQ9 significantly improved at Post in both groups
(p < 0.001). Pre- and post- data for peak METs, RHR, SBP, DBP, BMI, and PHQ9 are presented
in Table 3.
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Table 3. Key Dependent Variables
Variable

Post

Pre

Post

Peak METs, mL/kg/min

3.1 ± 1.3

5.5 ± 2.6bc

3.4 ± 4.4

4.4 ± 2.5bc

RHR, bpm

72 ± 14

74 ± 13b

68.7 ± 16.1

73.0 ± 14.7b

SBP, mmHg

126 ± 18

127 ± 15

128.1 ± 12.1

132.0 ± 17.6

DBP, mmHg

75 ± 10

76 ± 10b

74.9 ± 9.5

80.0 ± 9.1b

BMI , kg/m2

30.0 ± 6.0

29.8 ± 5.9

29.8 ± 6.8

29.8 ± 6.7

4.6 ± 5.5

2.4 ± 4.0b

4.2 ± 4.4

2.0 ± 3.2

b

Data are presented as mean ± SD

b
c

HBCR

Pre

PHQ9
a

TCR

Significant difference from Pre to Post

Significant difference between intervention group

d

Abbreviations: METs, metabolic equivalents; RHR, resting heart rate; SBP, systolic blood pressure; DBP, diastolic

blood pressure; BMI, body mass index; PHQ9, patient health questionnaire-9
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DISCUSSION
Cardiac rehabilitation improves exercise capacity and quality of life in individuals with
cardiovascular disease and/or those who have experienced a cardiac event/procedure48-50, 253, 263.
HBCR is a pragmatic alternative that can overcome commonly reported barriers as reported
numerous randomized-controlled trials (e.g., travel distance)41,

253, 257, 271, 274

. The current

investigation extended upon this work utilizing a retrospective study design with an organic,
observational approach to examine the effectiveness of home-based cardiac rehabilitation. The key
finding was an improved exercise capacity, as measured by peak METs, in both the traditionaland home-based cardiac rehabilitation groups. Although exercise capacity was improved in both
groups, the traditional cardiac rehabilitation group experienced greater benefits. Another key
finding from the investigation was improvements in depression scores (PHQ-9) with both
traditional and home-based cardiac rehabilitation.
Traditional vs. Home-based Cardiac Rehabilitation
Exercise capacity is a well-established predictor for cardiovascular outcomes132, 328. Peak METs,
the selected variable for exercise capacity in the current investigation, significantly improved with
TCR and HBCR. The improvements in exercise capacity with TCR and HBCR observed are
consistent with previous literature from randomized-controlled trials262, 263, 271, 274. However, a
prospective study only observed exercise capacity improvements in TCR with a 12-week
intervention in heart failure patients261. Importantly, the study did not monitor the activity of homebased patients261. Supervised exercise programs increase adherence, which highlights the need to
better understand the efficacy of HBCR with minimal supervision261, 276. The current findings
extended upon this work and demonstrated improvements with both TCR and HBCR, even with
minimal supervision (weekly phone calls) in the HBCR program. Although greater improvements
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were observed with TCR, the observed improvements in both interventions were clinically
meaningful. Exercise capacity improvements increased by an average of ~ 2.4 METs in the TCR
program and ~1.0 METs in the HBCR program, and evidence suggests a 1-MET increase in
exercise capacity improves survival by 12%132. These findings support the notion that HBCR is a
sufficient, beneficial method if/when a traditional, on-site program is not as accessible (e.g., rural
patients).
RHR, SBP, and DBP provide insight regarding all-cause mortality and the risk of cardiovascular
events136, 141, 150, 151, 153. Previous work examining HBCR has produced mixed results regarding the
effect of the intervention on RHR, SBP, and DBP253, 259, 271, 274, 275. Few investigations examining
HBCR have demonstrated improvements in RHR253, 271. Of note, RHR is influenced by betablockers, a medication commonly prescribed to cardiac patients. Consequently, results are affected
by medication compliance and/or changes in prescribed dosage. Interpretation of the RHR data
within the current investigation are limited due to the inability to consistently monitor dosage
changes and/or compliance with the medication. Additionally, no improvements were observed in
SBP or DBP, which is consistent with previous literature256, 257, 259, 263, 265, 274, 275. Although HBCR
did not improve RHR, SBP, and/or DBP, it is necessary to highlight improvements were not
observed with on-site rehabilitation; thus, HBCR did not produce inferior results by comparison.
Depression
Depression is a common comorbidity for those with CVD that hinders adherence to exercise
programs237, 239, 240. Importantly, 20-45% of patients that experience a cardiac event present with
depression238. The link between clinical depression and poor outcomes in those with CVD have
led the American Heart Association to consider it a risk factor, highlighting the importance of
improving symptoms of depression in cardiac rehabilitation patients239. The PHQ-9 is a
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convenient, pre-diagnostic screening metric to identify clinical depression in cardiac rehabilitation
patients, with a score ≥ 5 indicating mild depression, ≥ 10 indicating moderate depression, and ≥
20 indicating severe depression329. The relationship between exercise and improvements in
symptoms of depression is well-established; however, research on the effectiveness of cardiac
rehabilitation to improve symptoms of depression has produced mixed results155, 242-244, 330. A
recent investigation of 21,000 cardiac rehabilitation patients demonstrated ~40-48% experienced
improvements in PHQ-9 scores, an overarching finding which was independent of sex, race, and
ethnicity (Quindry et al in review); however, these findings are limited to TCR because HBCR
was not examined. Specific to HBCR, Kraal et al. examined the effect of on-site and home-based
cardiac rehabilitation on PHQ-9 scores in a sample of 90 patients and observed no improvements
following rehabilitation262. The findings of the current investigation support that cardiac
rehabilitation improves symptoms of depression due to the observed decrease in PHQ-9 scores
following both TCR (Pre: 4 ± 4, Post: 2 ± 3) and HBCR (Pre: 5 ± 5, Post: 2 ± 4). Further research
is needed to determine if HBCR is associated with improvements in PHQ-9 scores.
Completion
The well-established health benefits of cardiac rehabilitation are dependent on program
participation and adherence to exercise. However, most eligible patients do not enroll in
rehabilitation and many engage in participation withdrawal within the first six months331.
Accordingly, intervention methods should focus on increasing program participation and
completion. The current investigation observed a 49.3% completion rate in TCR and a 59.3%
completion rate in HBCR. These findings are in agreement with previous literature demonstrating
that 25-50% of patients do not complete rehabilitation332,

333

. Importantly, statistical analysis

indicated no association between the type of intervention and program completion, indicating that
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both TCR and HBCR exhibited suboptimal adherence rates. Additionally, the current investigation
was conducted in a region with limited metropolitan area (<120,000 residents) and a proportionally
large number of rural patients (> 30-minutes from the cardiac rehabilitation center). Travel
distance is a known predictor of non-participation in cardiac rehabilitation331, a fact that may have
been amplified in this population due to long winters and mountainous driving. Interestingly, when
examining completion rates for rural patients, completion rates were 51.3% for TCR and 89.7%
for HBCR. The results indicate that HBCR has the potential to offset the non-participation
observed with greater travel distances. Future research should examine the efficacy of HBCR with
a sufficient sample size.
COVID-19
The current investigation coincided with the COVID-19 pandemic, which lead to the development
of the HBCR program due to on-site closures, ultimately providing a unique opportunity for this
retrospective analysis. A limitation of this study is that information regarding vaccination status
and/or infection with COVID-19 was only available for those who underwent vaccination or
testing at St. Patrick’s Hospital; thus, limiting our ability to draw conclusions regarding COVID19 infection and/or vaccination status. Nonetheless, 66% of HBCR patients and 76% of TCR
patients reported being fully vaccinated. Of these individuals, 31% of HBCR patients and 56% of
TCR patients were boosted. The vaccination status of the remaining patients was unknown.
Regarding COVID-19 infection, four total infections were reported during the rehabilitation
intervention (TCR: n = 4, HBCR: n =1). An interesting consideration for the investigation was
how COVID-19 would impact intervention selection (TCR or HBCR) and/or withdrawal from
rehabilitation. However, only one individual reported selecting HBCR due to concerns related to
COVID-19, and three TCR patients reported withdrawal due to concerns related to COVID-19.
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Limitations
Female patients typically experience low referral rates and often report different barriers to entry
than their male counterparts74-77. Unfortunately, sample size was insufficient for statistical analysis
of sex-dependent differences in the current investigation. Thus, future research should seek to
examine the efficacy of home-based cardiac rehabilitation specific to female populations. Another
key limitation in the investigation was the ability to monitor alterations in prescribed doses of
medications that impact the key dependent variables (e.g., blood pressure, heart rate). However,
individuals prescribed these medications were identified at the time of enrollment in the
intervention. Finally, the representation of various race and ethnic groups were limited in the
investigation by virtue of regional demographics.
Conclusion
This retrospective study compared TCR and HBCR and determined both interventions resulted in
improvements in peak METs and PHQ-9 depression scores. Supervised exercise programs
increase exercise adherence; thus, this investigation examined HBCR without the research-based
supervision that occurs with randomized-controlled trials. The results of the current investigation
provides evidence that HBCR improves exercise capacity (peak METs) and outcomes of
depression (PHQ-9). TCR resulted in greater increases in peak METs; however, HBCR averaged
an increase of ~1 MET indicating it is a sufficient method of rehabilitation for those with long
travel distances, a known predictor of non-participation331. Additionally, both TCR and HBCR
improved symptoms of depression, as indicated by the PHQ-9, independent of the type of
intervention. This retrospective study was novel due to this inclusion of all enrolled patients,
regardless of their diagnosis, demonstrating that HBCR can improve exercise capacity and
depression outcomes across a variety of patients.
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